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Computational Contributions Towards Scalable and Efficient Genome-wide Association Studies 
Snehit Prabhu 
Genome-wide association studies are experiments designed to find the genetic bases of physical 
traits: for example, markers correlated with disease status by comparing the DNA of healthy 
individuals to the DNA of affecteds. Over the past two decades, an exponential increase in the 
resolution of DNA-testing technology coupled with a substantial drop in their cost have allowed 
us to amass huge and potentially invaluable datasets to conduct such comparative studies. For 
many common diseases, datasets as large as a hundred thousand individuals exist, each tested at 
million(s) of markers (called SNPs) across the genome. 
Despite this treasure trove, so far only a small fraction of the genetic markers underlying most 
common diseases have been identified. Simply stated - our ability to predict phenotype (disease 
status) from a person's genetic constitution is still very limited today, even for traits that we 
know to be heritable from one's parents (e.g. height, diabetes, cardiac health). As a result, 
genetics today often lags far behind conventional indicators like family history of disease in 
terms of its predictive power. To borrow a popular metaphor from astronomy, this veritable 
"dark matter" of perceivable but un-locatable genetic signal has come to be known as missing 
heritability. 
This thesis will present my research contributions in two hotly pursued scientific hypotheses that 
aim to close this gap: (1) gene-gene interactions, and (2) ultra-rare genetic variants - both of 
which are not yet widely tested. First, I will discuss the challenges that have made interaction 
  
testing difficult, and present a novel approximate statistic to measure interaction. This statistic 
can be exploited in a Monte-Carlo like randomization scheme, making an exhaustive search 
through trillions of potential interactions tractable using ordinary desktop computers. A software 
implementation of our algorithm found a reproducible interaction between SNPs in two calcium 
channel genes in Bipolar Disorder. Next, I will discuss the functional enrichment pipeline we 
subsequently developed to identify sets of interacting genes underlying this disease. Lastly, I will 
talk about the application of coding theory to cost-efficient measurement of ultra-rare genetic 
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Chapter 1. Introduction 
In June of 2000 at a crowded press conference in the white house, President Clinton announced 
that the first effort to map the entire DNA sequence of a human being had been successfully 
completed (White House Press Release). From its inception, the effort had been eulogized as a 
landmark scientific endeavor: one that would see the creation of the first roadmap of the human 
genome, the bedrock upon which many a future medical breakthrough would rest, and the 
forbearer of a genetic information based public healthcare revolution. High stakes – some  
commercial, some controversial, and most pertaining to a scientific legacy (a.k.a. “props”) – saw 
the emergence of a fierce race to the finish line between two groups, with the large government-
funded Human Genome Project (HGP) initiative led by Francis Collins pitted against a private 
biotechnology startup called Celera Genomics founded by Craig Venter. As it turned out, the 
teams were relying on two very different experimental strategies, revealing an important 
difference in ideology. The HGP would use the more painstaking and deliberate approach of 
sequencing DNA in fragments of staggered length in the wet-lab, thereby making the genome-
jigsaw easier to assemble computationally. Meanwhile Celera would rely on the (at the time 
quick-and-dirty) shotgun sequencing approach that only provided short, less informative DNA 
reads, but it did so more economically and at a faster pace. These short DNA strings would be 
used in conjunction with sophisticated algorithms running on large supercomputers to manage a 
more difficult assembly process. Eventually, the race was called a tie and credit was officially 
awarded to both teams, with both Venter and Collins standing beside the president during the 





In a way, the effort to sequence the first genome marked the unofficial birth of the now 
burgeoning field of computational genetics. Along with a few surprises (e.g. the human genome 
only had ~20K genes, not 100K as predicted by most models at that time), the project had 
underscored the importance of advanced computational and statistical methods in studying all 
things genome. Another outcome was that dropping costs and established protocols would allow 
concurrent, cheaper and more informative sequencing efforts. Two such projects, the Human 
Genome Diversity Panel (HGDP) and the Haplotype Map (Hapmap) (Hapmap Consortium 2003; 
Cann 2002) were outlined to study the genetics different human populations and to develop a 
better understanding of the entire spectrum of genetic variation – both between and across 
populations – on a genome-wide scale. A feature of particular interest was SNPs (Single 
Nucleotide Polymorphisms): sites at which at least an estimated 5% of humans were 
polymorphic. These “common” genetic variations were initially defined as positions in the DNA 
where >5% of chromosomes in the tested populations harbored one nucleotide (say A), while the 
<95% remaining chromosomes in the population carried a different nucleotide (say G). The 
subsequently revised, broader definition used today considers any polymorphisms straddling a 
1%-99% division to be a SNP. Although the existence of these polymorphisms was well known, 
their incidence across the whole genome was systematically characterized for the first time.  
Importantly, identifying all SNPs would bring us closer to understanding the connections 
between genetic variation and differences in physical characteristics. Since the genomes of two 
randomly chosen individuals differ in very few locations (a current estimate is 0.1%, although 
the exact sites difference may vary from individual-pair to individual-pair), in some sense the 





of trait variation. The first genetic studies on a genome-wide scale were to focus on these 
“eigen”-sites1. Once a identified, much cheaper technology could be used to test an individual at 
a particular site of interest (for example, whether an individual was AA, AG or GG). This 
technology, called genotyping by hybridization, had so far only been applied to test a few 
hundred known polymorphisms on a few genes of interest. With the complete catalog of SNPs, 
new assays containing hundreds of thousands of sites allowed genotyping human DNA at an 
unprecedented scale.  
Although the choice of a 5% (later 1%) frequency threshold was arbitrary and stemmed largely 
from technological limitations, the availability of a low-cost high-quality picture of genetic 
variation across the whole genome (and not just a few genes or loci) gave rise to a decade of 
genome-wide association studies (GWAS). These were experimental designs that compared the 
genomes of related or unrelated individuals in the hope of finding polymorphisms that were 
correlated with phenotypic (i.e. trait) differences. The following decade saw an onslaught of 
successful studies on a wide variety of diseases and traits, each uncovering a few causal variants 
by examining millions of markers (Manolio et al. 2009). However, it quickly became apparent 
that runaway successes – finding a single genetic variant that explained all or most of disease’s 
incidence – were mostly limited to rare genetic aberrations affecting a small minority of the 
population. These were diseases whose genetic “simplicity” could be inferred by observing their 
                                                 
1
 It is important to note the difference between correlation and causality. Although it was unlikely that SNPs 
themselves would be responsible for differences in traits, they were expected to reveal causal variants in their close 
proximity that were. This ability of genetic polymorphisms to “tag” one another is due to the existence of linkage 
blocks – stretches of DNA that are likely to be inherited together from one’s parents. Intuitively, this results in 
polymorphisms close to each other becoming correlated. Asymptotically, the    (linkage disequilibrium) between 





classical inheritance pattern in families, in accordance with Gregor Mendel’s canonical 
principles.  
While the utility of genetic analysis on so-called Mendelian traits was unquestionable, for more 
common diseases of greater public health interest like diabetes, heart disease, immune disorders  
and most cancers, the genetic bases remained difficult to elucidate. Given their non-mendelian 
(and hence, “complex”) segregation patterns within families, an early guesstimation was that a 
set of variants, each contributing a partial effect towards the phenotype status were more likely to 
be responsible. That is, instead of a single fully penetrant mutation like in the case of Mendelian 
traits, there would be multiple variants, each of incomplete penetrance (see Figure 1-1). This 
prevailing opinion was formally stated in 1996 as the Common Disease Common Variant 
(CDCV)  hypothesis (Risch and Merikangas 1996). CDCV held that a few common variants like 
SNPs – perhaps half a dozen or so – would be responsible for the entire genetic component of 
each common complex disease. This cautiously optimistic statement was made testable by the 
rapidly improving technology of the day (     SNP sites ascertained across the whole genome 
of each individual). Since then, genome-wide association studies under the CDCV design have 






Figure 1-1. Venn diagram panels to visualize key terms.  
(a) Consider a population   (grey box) containing   individuals affected by some common disease (red 
circle). The disease has an estimated              ⁄ . Consider a SNP (polymorphic site of DNA) in 
this population (blue circle). The individuals carrying the mutant (non-reference) allele lie within  , while 
the rest lie outside. The estimated effect size of this SNP is usually represented either by its            
   
 ⁄  , its      
   
   ̅
⁄ , or its            (   
   ̅
⁄ )  ( 
̅   
 ̅   ̅
⁄ ). 
(b) The “Common Disease Common Variant” hypothesis predicted that a few commonly occurring SNPs 
(large blue circles) would account for most or all of the incidence of common diseases.  
(c) After a decade of CDCV designed GWAS, statistically significant SNP associations were made for most 
diseases, but accounted for very little of the disease incidence –a few notable exceptions include Age-
related Macular Degeneration. 
(d) The present-day zeitgeist is to seek rare, high-penetrance mutations (small blue circles) each of which 
account for the high-disease incidence in genetic relatives (this may include socially unrelated individuals 
who are identical by descent), and cumulatively account for most of the disease in the population.  
(e) Again, notwithstanding a few exceptions, recent results seem to indicate that this is not the case for a 
majority of common diseases, at least concerning variants within the 1-5% frequency range. However, the 
hypothesis itself is far from spent, as whole-genome sequence (as opposed to genotype tagging) based 
GWAS designs that capture every single variation become economical. 
An unequivocal way to measure the contribution of genetic associations is to test our ability to 
predict an individual’s phenotype (like disease status) from genotype. Stated in terms of a linear 





variation like SNPs as predictive features ( ), we can ask questions about the predictive power 
of genetics:       . We recall here that one arrives at the best-fit in a linear regression by 
minimizing squared residuals – the proportion of variation in the dependent variable   that 
simply cannot be accounted for using a linear combination of the predictors  . As it turned out, 
although GWAS had statistically associated thousands of SNPs with nearly a hundred common 
diseases, the trait variance explained by these genetic features remained miniscule (Manolio et 
al. 2009). The fact that the phenotypes chosen were known to have a clear and perceivable 
genetic basis was established through orthogonal methods – for example, monozygotic twins 
bearing strong resemblance in their trait value, or, the ability to predict offspring trait values 
from parental trait values with high accuracy. Despite this, finding the precise genetic loci 
responsible for this trait (predictive power) and therefore by extension, explaining variation of 
the trait in the larger population (by minimizing residual variance) has turned out to be quite 
difficult. This has come to be known as the “missing heritability” problem (Maher 2008).  
Over the past few years (roughly 2008 onwards, which was the period of my PhD), several 
hypotheses have been put forward to bridge this gap between heritable phenotypic variance and 
explained genotypic variance. One ambitious viewpoint held that the functional forms used to 
model genotype-phenotype relationship – i.e.   in        – were inadequate. So far, GWAS 
methods have used kernels that model SNPs acting in isolation, and in a manner that lets their 
cumulative effect on disease predisposition behave additively. The alternate viewpoint predicted 
that higher-order models incorporating combinations of variants (e.g. interaction kernels on pairs 
or triples of SNPs) might expose causality (Marchini et al. 2005). There was certainly sufficient 





several theoretical results and studies on simulated human datasets suggested the widespread 
existence of interactions that leave a negligible-to-nil association signature on their constituent 
SNPs (Cordell 2009; Evans et al. 2006a). If this were true, it would explain to some extent why 
traditional GWAS have found it so difficult to associate these loci. More pertinently to me, the 
reason this hypothesis had not made much headway as yet was due in no small part to the 
formidable computational challenge of testing pairwise (or indeed three-way) combinations of 
millions of SNPs routinely assayed on contemporary genotyping chips – a perfect recipe for 
stimulating CS PhD research. 
The first research section of my doctoral thesis (Chapter 2) describes contributions made towards 
genome-wide SNP-SNP interaction testing. Specifically, we focused on alleviating the       
burden of testing all pairwise combinations of SNPs adopted by most state-of-the-art methods. 
While a few methods had attempted this by making lossy, simplifying assumptions (pre-selection 
of a few candidate SNPs based on biology, or in a greedy approach based upon their marginal 
association level), these had failed to get at the heart of the problem. Our objective was to 
address these limitations from both a theoretical and a software implementation standpoint.  
First, we noted that in accordance with established methodology, SNP-SNP interactions would 
need to exceed a threshold of statistical significance (in this case, a p-value) before they might be 
robustly claimed as interactions. Since the number of SNP-pairs we test is in the order of 
trillions, statistical procedure dictates that this threshold is set fairly high – or in our case, a very 
low p-value cutoff. This is done in order to avoid false positive discoveries: red herrings where 





given the limited size of human GWAS datasets (empirical evidence), any SNP-pair that 
exceeded the significance cutoff would also leave behind telltale statistical signatures. To our 
advantage, one of these signatures was exploitable by a classic Monte-Carlo randomization 
scheme. Our software implementation of this algorithm, SIXPAC, provides a solution to this 
computationally hard problem with high probability of success, within a fraction of the compute 
time used by comparable deterministic algorithm. As it turned out, the “limitation” of low 
statistical power (i.e. dataset size) could be exploited for a computational benefit. 
Chapter 3 of this thesis addresses the other side of the coin – statistical limitations of genome-
wide interaction mapping due to insufficient data points (i.e. samples). Besides building more 
powerful statistical indicators, the most widely used computational approach to extract biological 
insight from vanilla GWAS is called functional enrichment. Briefly, the procedure involves 
grouping SNPs into functional categories and to test the significance of each group. We used one 
of the most widely used and well established functional definition database, the Gene Ontology 
(GO). As the name indicates, the GO database assigns function to genes rather than SNPs, and 
therefore necessitates a staggered approach: combining SNP p-values into gene p-values, before 
subsequent testing for enrichment of gene-groups is possible. Although techniques to do 
ontology enrichment from a list of SNP associations were adequately described in the literature, 
ontology-ontology enrichment from a list of SNP-SNP interactions had never before been 
attempted in an exhaustive, genome-wide manner. The availability of high-speed software like 
SIXPAC now made this possible: motivating us to adapt the entire single-locus enrichment 
pipeline to interaction analysis for the first time. In this chapter, we describe the algorithm 





disorder. Interestingly, these results suggest the presence of interacting/dependent biological 
function groups underpinning this trait, although additional validation will be required to make a 
strong claim.  
Rather than interaction, a different hypothesis seeking to explain missing heritability has 
garnered the most scientific attention of late. This theory posits that rare variations – perhaps 
even mutations limited to one individual or one affected family in the population – might 
cumulatively be responsible for a large portion of common disease incidence (McClellan and 
King, 2010). In other words, although nosological labeling of patients may suggest the same 
disease, many and disparate genetic aberrations might underlie each ailment, and perhaps the 
perceived pathophysiological effect of each variation is what appears to be the same. Essentially, 
the hypothesis furthers the idea that a main (linear additive) effects architecture – the simplistic   
in our metaphorical        – is still the most likely to find new loci. The difference is that 
instead of genotyping a few common markers as we did earlier, we can apply cheap sequencing 
technology to directly ascertain these rare and ultra-rare variants today. Moreover, if this 
increase in our set of predictor variables is accompanied by a loss of statistical power (known as 
a propensity for overfitting in machine learning literature), then we might best address this by 
increasing the size of our datasets. Lastly, to ameliorate any concern that a single ultra-rare 
variant can only account for so much disease incidence (see very small blue circles in Figure 1-1) 
is the fact that rare genetic variation is turning out to be more ubiquitous than we expected 
(McClellan and King, 2010). Some estimates suggest that almost every site in the DNA has 





hypothesis has recently gathered considerable momentum today, concurrently with the onset of 
cheap yet high-quality sequencing technology (although the direction of causality is debatable).  
If it is true, then validating the rare-variant hypothesis with current technology will require a 
tremendous economic investment – whole-genome sequencing of tens of thousands of individual 
does not come cheap. However, it is far more likely that advances in in silico methods will help 
us make experimentation feasible, just like it has in the past. As an indication, the first human 
genome sequence cost the HGP an estimated USD       (or approximately $1 per site, given 
the 3.3 billion nucleotide sequence of human DNA), while it cost Celera approximately USD 
        Since then, although sequencing throughput has increased rapidly, costs have spiraled 
downward to an approximate USD        per genome today, representing a million fold 
reduction in vitro. An ironic outcome of this pace of development (faster than Moore’s law 
(NHGRI whitepaper)) has been a shift in the cost bottleneck from sequencing chemistries to 
information storage and processing. Whereas early projects would handle a few million precious 
DNA reads, today’s machines routinely generate billions of reads that present a high-quality but 
several-fold redundant picture of the sequenced genome. The erstwhile intangibles of storing, 
computational mapping and assembling of the genome from its pieces now dictate a sizeable 
fraction of most projects’ budgetary allocations. Regardless of the source of cost, it is safe to say 
that an efficient strategy is to exercise restraint with sequencing throughput, but to retain enough 
redundancy that allows us to confidently discover ultra-rare variation. 
One promising idea is pooled DNA sequencing. As the name implies, a single culture is prepared 





sequencing lane – as if we were sequencing DNA from a single individual as usual. Although 
this technique allowed us to detect the presence of a rare variant and to estimate its frequency in 
the dataset, it is obvious that the identity of the mutation carrier is lost. The utility of intelligently 
designed pools – sequencing each individual in a unique set of lanes so that it was possible to 
reconstruct carrier identity – was apparent, and it presented us with an opportunity to apply off-
the-shelf coding schemes that are so widely studied in computer science. Besides introducing 
relatively straightforward concepts of logarithmic codes and error correcting codes to this 
application, we also studied more applied issues of random/probabilistic errors that creep in at 






Chapter 2. Ultrafast SNP-SNP interaction mapping in large genetic datasets. 
Summary: Long range gene-gene interactions are biologically compelling models for disease 
genetics and can provide insights on relevant mechanisms and pathways. Despite considerable 
effort, rigorous interaction mapping in humans has remained prohibitively difficult due to 
computational and statistical limitations. In this section, we introduce a novel algorithmic 
approach to find long-range interactions in common diseases using a standard two-locus test 
which contrasts the linkage disequilibrium between SNPs in cases and controls. Our ultrafast 
method overcomes the computational burden of a genome × genome scan by employing a novel 
randomization technique that requires 10X to 100X fewer tests than a brute-force approach. By 
sampling small groups of cases and highlighting combinations of alleles carried by all 
individuals in the group, this algorithm drastically trims the universe of combinations while 
simultaneously guaranteeing that all statistically significant pairs are reported. We show that our 
implementation can comprehensively scan large datasets (2K cases, 3K controls, 500K SNPs) to 
find all candidate pairwise interactions (LD-contrast        ) in a few hours – a task that 
typically took days or weeks to complete by methods running on equivalent desktop computers. 
We applied our method to the Wellcome Trust bipolar disorder data and found a significant 
interaction between SNPs located within genes encoding two calcium channel subunits: RYR2 on 
chr1q43 and CACNA2D4 on chr12p13 (LD-contrast test            ). We replicated this 
pattern of inter-chromosomal LD between the genes in a separate bipolar dataset from the GAIN 
project, demonstrating an example of gene-gene interaction that plays a role in the largely 





2A. Background.  
Genome-wide association studies (GWAS) have successfully identified hundreds of genetic 
markers associated with a wide range of diseases and quantitative traits (Hindorff et al. 2009; 
Manolio et al. 2009). Unfortunately, for most common diseases, nearly all associated variants 
have small effect sizes and taken together explain very little of the genetically heritable variation 
of the phenotype (Craddock 2007) - a phenomenon often posed as the conundrum of “missing 
heritability” (Maher 2008). Furthermore, single-locus association methods (e.g. considering one 
SNP at a time and measuring its association levels to the phenotype) tend to implicate individual 
genes in a particular disease or trait, which in turn highlight a single biological entity involved 
(Saunders et al. 1993; Hugot et al. 2001; Benjamin M Neale et al. 2010). They do not, by 
definition, seek to implicate links between the functional elements of a system or elucidate 
pathway connections that may be broken. Investigation of joint gene–gene effects can therefore 
improve the explanatory ability of genetics twofold. Firstly, interaction - or statistical epistasis, 
as defined by (Fisher 1918) - is hypothesized to explain a part of disease heritability (Evans et. 
al., 2006; Marchini et. al., 2005) Secondly, finding significant statistical links (epistatic or 
otherwise) between genes could provide strong indications of molecular-level interactions that 
differ between cases and controls.  
However, an all-pairs (or all-triples) scan of SNPs genome-wide still poses widely discussed 
computational challenges due to the sheer size of the combinatorial space (J Marchini et al. 
2005), both for data sets typed on genotyping arrays (     SNPs) and sequencing technologies 
(     single nucleotide variants - or SNVs). Some methods address this problem by restricting 





single-locus analysis or those of biological interest (Emily et. al., 2009) or by only checking for 
interactions between SNPs that are physically close to one another on the genome (Slavin et al. 
2011). Others like EPIBLASTER (Kam-Thong et al. 2010) and SHIsisEPI (Xiaohan Hu et al. 
2010) make use of specialized hardware like multiple Graphical Processing Units (GPUs) to 
finish computation on genome-wide data sets on the order of days, rather than weeks or months. 
While it is known that reductionist, candidate SNP-based approaches can miss many real 
interactions (Culverhouse et al. 2002; Evans et al. 2006b) and fail to provide novel biological 
insights in an unbiased manner, brute-force approaches that rely on hardware for speedup may 
also scale poorly as data sets increase in size and interaction tests increase in complexity.  
For genome-wide interaction analysis to become pervasive, there is a pressing need for 
algorithmic insights that make interaction testing on large datasets a scalable proposition, 
without placing undue computing or hardware demands on the investigator. The contribution of 
our work is such a method. Recently, others had exploited the fact that contrasting/comparing the 
linkage disequilibrium (Jinying Zhao et al. 2006), Pearson correlation (Kam-Thong et al. 2010) 
and log-odds ratio (Plink “--fast-epistasis” option) between a pair of SNPs in cases and controls 
could be computed more efficiently than maximum likelihood estimates in a logistic regression. 
Usefully, these computationally efficient contrast tests showed high congruence with statistical 
epistasis under a variety of genetic models. In this study, we do not devise a new statistical test; 
rather, we use a simplified version of the LD-contrast test for interaction (Jinying Zhao et al. 





unlinked (often inter-chromosomal) SNPs that are in strong LD in cases, but in weak LD, no LD, 
or reverse LD in controls.
2 
Our computational approach is driven by the intuition that most genome-wide interaction 
methodologies only report SNP pairs that are statistically significant (as per the test used) after 
correcting for the number of tests. The question we ask is this: given a statistical test, is it 
possible to identify approximately all the significant SNP pairs with high probability (power), 
without actually applying the test to all possible combinations genome-wide? In practice, can we 
design a search algorithm that accepts an arbitrary significance cutoff (as input from the user), 
and then finds all SNP pairs that will pass this cutoff without a brute-force search? We show here 
that for some contrast tests, this is indeed possible. At this juncture, it is imperative that we point 
out the two distinct meanings of “power”: Here, unless otherwise specified, we mean the power 
of an algorithm to identify SNP pairs for which a test statistic is large (i.e., significant), whereas 
in the broader context of genome-wide interaction mapping literature, power is the ability of a 
statistical test to detect a real interaction in the data set. Our work focuses on addressing the 
computational issues that plague an exhaustive search for interaction, leaving issues of statistical 
power for a separate discussion.  
The rest of this chapter is structured as follows. First, we briefly review a simple LD-contrast test 
that compares LD between binary allelic states (rather than 0/1/2 genotypes) in cases and 
controls. Next, we present a novel computational framework—probably approximately complete 
                                                 
2
 Disequilibrium between physically unlinked loci is also often called Gametic Phase Disequilibrium (Wang et al. 
2010), but for purposes of this study, we consider both terms equivalent—in particular, we do not imply physical 





(PAC) testing—that quantifies the power of a search done by an algorithm. PAC is an intuitive 
concept: For example, a brute-force method that tests all-pairs of SNPs genome-wide is 
considered fully powered at finding all significant pairs in our framework (i.e., 100% probability 
of finding all pairs whose test statistic clears the significance cutoff) and have no element of 
approximation at all (i.e., 100% complete scan of the interaction space in the case-control data 
set). In this study, we design a two-stage PAC test for common complex diseases that is 
guaranteed to find all significant pairwise interactions with high power (e.g., probability >95% of 
finding all pairs with a significant statistic) by looking at almost the entire space of possibilities 
(e.g., ∼99% complete scan of interaction space). In return for accepting a small loss of certainty 
and power, we show that algorithms that offer tremendous computational gains can be designed. 
We evaluate the performance of our implementation of this framework (SIXPAC) on genome-
scale data and then present the results of our analysis on bipolar disorder (BD) in the Wellcome 







Outline: The goal of our method is to efficiently identify the set of SNP-pairs which have vastly 
different LD in cases and controls from the universe of pairs genome-wide - if any such pairs 
exist at all. First, we define the LD-contrast statistic and establish a minimum cutoff value that 
determines whether a pair of SNPs has a statistically significant contrast in a genome-wide study 
or not. Next, we devise a stage-1 filtering step that identifies potential case-control differences in 
LD by looking for LD in cases alone. We quantify the losses that stage-1 incurs (false negatives) 
by applying this “approximate” version of the full LD-contrast test.  
In stage 2, the candidates shortlisted based on their LD in cases are tested using the full cases-
versus-controls LD-contrast test, and either validated or discarded based on the difference. Stage 
2 is needed to distinguish stage-1 shortlisted candidates that are true interactions from false 
positives. False positives may include SNP-pairs drawn by pure chance, and also pairs which 
show large LD in cases, but also show large LD in controls in the same direction. Such a 
systemic inflation of disequilibrium between alleles in cases and controls might be due to other 
factors like population stratification, technical artifacts or ascertainment bias and is, by 
definition, not associated with phenotype. 
The motivation for dividing the search into two stages is because the stage-1, case-only, 
“approximate” filtering step can be processed extremely rapidly by exploiting computer bit-wise 
operations, making it much faster than a brute-force approach. We present the novel 
randomization technique called group-sampling with which we can efficiently find SNP-pairs 





sampling when we are reasonably certain that all significant (high LD) candidates have already 
been encountered and shortlisted. Consequently, at the end of stage-1, we are left with a 
“probably complete” list of pairs that demonstrate severe LD in cases.  Taken in conjunction, this 
design outputs a “Probably Approximately Complete” (PAC) catalog of interacting SNP-pairs at 
the end of the filtering stage, which are subsequently screened by the full test. We demonstrate 
that our software implementation of this PAC-testing framework can find approximately all 
significant SNP-pairs in current GWAS datasets with arbitrarily high power (e.g. >99% 
probability) at a fraction of the computational cost of an exhaustive search. 
Definitions and Notation: For purposes of illustration, consider two binary matrices      and 
    , representing the cohorts of   haploid cases and   haploid controls typed at 
  polymorphic sites respectively (we will extend this to the diploid human case later).      
denotes the allele carried by case   at variant site   (0 for major, 1 for minor), while      similarly 
denotes the allele carried of control   at that site. Further, we respectively denote        
|          | and        |          | as the number of cases and controls that carry allele 
        at  . Therefore,                ⁄    and                ⁄   are the corresponding 
allele  -frequencies of   in cases and controls. Since we are only discussing binary carrier 
states      , for ease of notation we henceforth use    instead of      , and (      instead of 
      (and analogously,     and      for controls). 
We are interested in examining whether a haploid individual carries a certain combination of 





individual can carry any one of    unique allelic combinations. We say an individual carries 
allelic state  ⃗                 
  , at these sites if she carries allele    at each one of the 
respective sites   . Analogous to individual sites, we can also denote the  
  different  ⃗-
frequencies of  ⃗  by   ⃗⃗  ⃗     ⃗⃗  ⃗  ⁄  in cases and   ⃗⃗  ⃗     ⃗⃗  ⃗  ⁄  in controls, where 
  ⃗⃗  ⃗          ⃗⃗   ⃗   and   ⃗⃗  ⃗          ⃗⃗   ⃗   are the number of  ⃗ carriers at   ⃗ in cases and 
controls respectively. For example, if an individual carries 1-alleles (i.e. minor alleles) at each of 
the sites  ⃗           , then we say she is a  ⃗⃗-carrier of  ⃗.  The  ⃗⃗-frequency of  ⃗  in cases 
(controls) is the fraction of cases (controls) that are  ⃗⃗-carriers of  ⃗. 
Binary representation of diploid genomes: For diploid genomes like humans, equivalent 
matrices of cohorts would be      for cases and     , for controls, where each entry         in 
these matrices represents the number of minor alleles at the site, rather than presence or absence 
of a minor allele. Depending on the model of interaction the investigator is interested in, these 
may be transformed into an appropriate binary representation in several ways. For our purpose, 
we represent each ternary genotype as two binary variables. The first variable asks whether the 
individual carries    copies of the minor allele (i.e. is dominant) at this SNP, while the second 
asks whether the individual carries exactly   copies of the minor allele (i.e. is recessive) at this 
SNP. In this format, cases and controls are represented by the binary matrices       and        
respectively, where each genotype      is recoded as two binary values                 for cases, 
         {
                 
                 
                            {
                 






and      is recoded equivalently as                 for controls.  For example, case #6 is 
represented as a recessive carrier of SNP #12 (variable coordinates: row 6, column          
by setting         . If case #6 is a dominant carrier of SNP #12 then we set both         and 
       . The notations for number of carriers and frequency of variables (and combination of 
variables) all follow analogously.  
Statistical Test for Two-Locus Effect: We adapt the LD-contrast test for interaction between a 
pair of unlinked genotypes (Zhao et al., 2006) into a similar two-tailed test between a pair of 
unlinked binary variables  ⃗         , 
   ⃗⃗
     
  ⃗⃗
        ⃗⃗
       
√(  ⃗⃗
    )
 
  (  ⃗⃗
       )
 
        
Equation 2-1 
where   ⃗⃗
     and   ⃗⃗
        represent the estimated LD between these variables in cases and 
controls respectively, while   ⃗⃗
     and   ⃗⃗
        represent the standard error of these estimators 
(see 7A. for derivation and details) and    ⃗⃗
    
 is their LD-contrast. This normalized statistic 
behaves as a Z-score, and for variable-pairs that pass the significance cutoff in a genome-wide 
pairwise analysis (typically         or less on present day datasets), this statistic will assume 





Variable-pairs with large differences in LD are of interest to several genetic models, and their 
signal can be dissected to either reveal statistical (epistatic) or biological interaction. Based on 
what is known about the genetic architecture of a specific disease,  the relevant community of 
geneticists can bring different model assumptions to bear on a test for interaction. Here, we do 
not attempt to dictate a specific model that might cause such a difference in LD between the 
cases and controls. Rather, we focus on presenting a general method that can report all SNP-pairs 
with a significant contrast and provide expert users with the flexibility to filter the results from 
such an analysis according to relevant assumptions. This can be done either apriori (e.g. 
removing SNPs with marginal signals before running a search for interaction), or aposteriori 
(e.g. discarding reported SNP-pairs that do not provide evidence for statistical epistasis).  
Two-stage testing design: A widely used simplification (Cordell 2009; Piegorsch et al., 1994; 
Yang et al., 1999) in genome-wide interaction scans is to divide the search effort into two stages 
- first filter candidates, and then verify interaction. The crucial insight that permits this step is 
that we can expect physically unlinked markers to be in (or almost in) linkage equilibrium in 
large outbred populations. Even for common diseases, the general population is mostly 
comprised of healthy controls (disease prevalence < 50%). We show that in the absence of 
confounding factors like population stratification a pair of physically unlinked variables showing 
large LD-contrast will be a pair which has large LD in cases rather than large LD in controls. 
Without loss of generality, we focus our discussion on identifying pairs with strong positive LD 
in cases (   ⃗⃗
       ). Pairs with strong negative LD between variables are easily modeled 
(with a trivial change in binary encoding) as strong positive LD between the major allele at one 





different binary encoding scheme, but introduce more confusing notation. A separate (but 
limiting) issue is that of the statistical testing burden incurred by encoding alternate models, 
which we address in the discussion. A sequential two-stage testing strategy is designed as 
follows.  
Stage 1 (Shortlisting): The stage 1 null-hypothesis states that any pair of distal variables 
 ⃗         should be in linkage equilibrium in cases. 
   
      ⃗⃗
     
  ⃗⃗
    
  ⃗⃗
       
Equation 2-2 
From Equation 7-1 we know the distribution of    ⃗⃗
     is        . We shortlist only those 
variable-pairs that reject the stage 1 null hypothesis at a significance level of   . In other words, 
for a pair to be shortlisted as a candidate for follow-up, we require that the LD in cases between 
its variables should exceed some threshold - i.e.    ⃗⃗
        
 . We will determine this threshold 
to satisfy sensitivity/specificity constraints later.  
Stage 2 (Validating): Next, we apply the LD-contrast test on candidates shortlisted by stage 1. 
This helps us to determine, for each candidate, whether the observed LD is indeed case-specific 
(and therefore a putative indicator of interaction) or pervasive in the population (and hence 
unrelated to disease). The stage 2 null-hypothesis posits that there is no LD difference between 





       ⃗⃗
       
Equation 2-3 
Putative significant pairs will reject this null hypothesis at a significance level of   ( i.e. 
   ⃗⃗
        ). 
In order to appreciate how such a two-stage design can capture almost all significant pairs in the 
dataset, and what the appropriate significance cutoff   
  in the stage 1 analysis must be, we now 
introduce the concept of a Probably Approximately Complete Search. A numerical example 
depicting the concepts that follow is provided in 0 
Probably Approximately Complete (PAC) Search: We now apply this two-stage hypothesis 
test into our probabilistic framework. 
A. Complete Search:  
To find all significant variable-pairs in the dataset, current algorithms would sequentially 
visit each pair of SNPs, genome-wide, and check whether each LD-contrast exceeds the user-
prescribed significance threshold (   ⃗⃗
       )  by comparing cases and controls. 
  
B. Approximately Complete Search:  
Here we ask, what threshold    ⃗⃗
       
   can we apply in the filtering step, so as to capture 
almost all significant pairs by means of their disequilibrium in cases alone. In other words, 
can most significant pairs (pairs for which    ⃗⃗





determining   ⃗⃗
        at all? Furthermore, we wish to determine the proportion of significant 
pairs that such an approximation might miss.  We show that for most common diseases, an 
adequate cutoff for LD in cases is usually   
      (see 7B. ) – i.e. SNP-pairs with a severe 
LD-contrast (difference in LD between cases and controls) are usually observable from their 
severe LD in cases alone.  
 
C. Probably Approximately Complete (PAC) Search:  
So far, our two-stage design has reduced the cumbersome task of counting the number of 
carriers for all variable-pairs (genome-wide) in cases and then again in controls, to the 
simpler task of shortlisting the small set of pairs which demonstrate    ⃗⃗
       
    . From 
a complexity standpoint however, such a simplification (restricting the stage 1 analysis to 
cases only) does not change the order or magnitude of the number of tests: this is still 
quadratic in the number of SNPs genome-wide. To address this computational problem we 
now introduce the novel randomization technique called group sampling, which can rapidly 
perform the case-only shortlisting with arbitrarily high power, without explicitly checking all 
pairs of variables. 
Next, we describe a novel Monte-Carlo sampling technique called “Group Sampling” that allows 
us to identify all interacting variable-pairs in a dataset, within the PAC paradigm. 
Group Sampling:  From our observation that the LD statistic in cases, is usually more severe 
than LD-contrast (7B. ), we deduce that significant interacting pairs  ⃗ will show a minimum 
number of excess  ⃗⃗-carriers in cases:    ⃗⃗
          ⃗⃗





universe of variable-pairs tested grows, so does the burden of multiple test correction that is 
applied to characterize statistical significance. Consequently, the number of excess of  ⃗⃗-carriers 
required in order for  ⃗ to achieve statistical significance in cases -    ⃗⃗
      - grows 
commensurately. Group sampling overcomes the computational burden of a genome-wide 
analysis by using this “side-effect” of multiple-test correction to its advantage: the larger the 
number of variants typed, the larger is the universe of pairs to be tested, and the larger the excess 
 ⃗⃗-carriers needed to make statistically significant pairs stand apart from the crowd - this 
observation allows us to quickly prune the universe of pairs into a much smaller candidate set 
that is “guaranteed” to contain all significant pairs with arbitrarily high probability.  
For illustrative purposes, let us consider a simplified version of the problem at hand. In this 
version, we are only interested in searching through pairs of distal variables  ⃗        , where 
both variables have 1-frequencies (   and    ) that lie within the narrow frequency window   
  ̃  ̃    . Let the set of all variables that lie within this frequency window be labeled     . We 
wish to determine whether there exists a pair  ⃗           , such that  ⃗ rejects   
 . We can 
compute a lower bound on   ⃗⃗
     for all such  ⃗  as: 
   
   
   ⃗⃗
          
   
  ̂ ⃗⃗
         






This is because the excess  ⃗⃗-carriers required for any  ⃗            to reject   
 is at least as 
many as the excess  ⃗⃗-carriers required by the least frequent  ⃗ in that set: when         ̃. 
Therefore the  ⃗⃗-frequency of all pairs that reject   
 is at least 
  ⃗⃗   ̃
  
   
   
   ⃗⃗
     
 
 
  ̃        
Equation 2-5 
where      
 ̃    ̃ 
√ 
    is the minimum LD in cases for all significant pairs  ⃗           . 
Randomly sampling a single group: Consider a group of   cases drawn randomly (with 
replacement). If  ⃗ rejects    
 , then the probability that all   cases in the group will be  ⃗⃗-carriers 
of  ⃗ has a lower bound    ⃗⃗ 
  ( ̃       )
 
. On the contrary, if  ⃗  does not reject    
 , then 
the probability that such a group will contain all  ⃗⃗-carriers of  ⃗ purely by chance has an upper 
bound    ⃗⃗ 
     ̃       – corresponding to the most frequent variable-pair in           . 
It is easy to see that if       , we are much more likely to observe a random group of cases 
that are all  ⃗⃗-carriers of  ⃗ when it rejects   
 .  
The reason for drawing cases in groups (as opposed to one by one) is that it allows us to rapidly 
find the subset of variables for which all   cases are  ⃗⃗-carriers. This is done with a native bitwise 
AND operation using computers, which is very fast in practice. In fact, the larger the group size, 





Furthermore, long stretches of binary genotype data can be processed per CPU clock cycle, 
making this step even more attractive. Subsequent to finding this small subset of variables, it is 
computationally efficient to enumerate all pairs (or indeed, triplets) among them, and pass them 
on to stage 2. 
 
Randomly sampling multiple groups: If the group of cases we draw is sufficiently large (i.e.   is 
high), then it is extremely unlikely to contain only  ⃗⃗-carriers, not only when  ⃗ accepts    
 , but 
also when this null is rejected : because both   ̃        ( ̃       )
 
  . We can counter 
this by drawing up to   independent groups (each containing   random cases), so that the 
probabilities of not witnessing even a single group containing only  ⃗⃗-carriers decreases at 
diverging rates for the two realities: 
(      ̃      )
 





In fact, if  ⃗ does reject   
 , then by varying the two parameters   and   the probability of 
observing at least one group of all  ⃗⃗-carriers can be driven arbitrarily high (Type II error rate < 
  ) while keeping the probability of a chance observation relatively low (Type I error rate <  ). 
In other words, given fixed specificity and sensitivity constraints   and   (provided as input by 
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Equation 2-6 
An illustration to visualize this technique is provided in Figure 2-1, while the simple algorithm 
implied by our toy problem logic is provided by Algorithm 1. The general formulation for PAC-
testing across all frequency windows (genome-wide) is described in 7D.  and the logic provided 
by Algorithm 2. 
Algorithm 1: Group Sampling Toy Problem. 
 
 
Algorithm 2: Group Sampling Genome-wide. 
a. Given all variables within frequency range      {  |        ̃   ̃      
b. Calculate significance threshold      
c. Calculate sampling parameters   and   
d. Repeat   times : 
e.  Randomly choose a group   of   cases (  rows from      ) 
f.  Co-carried variables                       
g.  For all unique combinations  ⃗               : 
If    ⃗⃗
        







h. Assign all variables genome-wide to frequency windows              
i. For every pair of windows              : 
j.    Calculate significance threshold      
k.    Calculate sampling parameters      and      
l.    Repeat      times: 
m.       Randomly choose group   of      cases  
n.       Co-carried variables                       
o.       Identify variables              
p.       Identify variables              
q.       For all unique combinations  ⃗                : 
r.          If    ⃗⃗
        
  do                        { ⃗ } 
s.       For all shortlisted variables  ⃗           : 
t.          If    ⃗⃗





This concludes our discussion of a PAC search, and the group-sampling algorithm by which one 
might construct a Probably Approximately Complete list of interacting SNPs.  These theoretical 
results can be realized in a powerful software implementation: as we shall demonstrate next, we 
can find approximately all significant SNP-pairs genome-wide with high power in a fraction of 
the time that an exhaustive search would require.  
 
Figure 2-1 Group sampling illustration.  
Sample   individuals per group, perform a simple and rapid binary AND operation that shortlist alleles carried by all 
individuals in the group, hash these pairs of co-occurring alleles and proceed to next sampling step. Stop sampling 
after   iterations. We show that this sampling technique provides a probably approximately complete picture of the 
SNP-SNP interaction landscape at a fraction of the computational cost, when compared against enumerating and 






The major methodological contribution of this work is a novel randomization algorithm (group 
sampling), which can focus the computational effort towards finding significant pairwise 
interaction candidates, without testing all pairs genome-wide. To determine whether a candidate 
SNP-pair is significant or not, and to minimize risk of false positives, in all our analyses we 
subject the results to the most conservative threshold for significance in a genome-wide analysis 
- the Bonferroni corrected p-value of 0.05 – unless otherwise stated. More sophisticated 
treatment of the multiple testing issues in interaction testing (e.g. (Emily et al. 2009a)) are 
equally applicable and can be plugged into our method without violating any of the principles or 
assumptions. We also restrict our analysis to pairs of genetic markers (SNPs) only, and choose to 
ignore gene-environment interactions for the moment. These simplifications serve to highlight 
the fundamental concepts of our approach, without loss of interpretable results. Our software 
implementation of this algorithm (SIXPAC) is available for download at 
http://www.cs.columbia.edu/~snehitp/sixpac. 
Dataset: SIXPAC was used to analyze 1868 cases of the Bipolar disorder (BD) cohort in the 
WTCCC against      combined controls from the 1958 British birth cohort (58C) and UK 
national blood service (NBS), all typed on the Affymetrix 5.0 platform, after cleaning all data as 
per requirement (Craddock 2007). Each of the remaining 455,566 SNPs remaining in the dataset 
was encoded into two binary variables (dominant and recessive), giving 911,132 binary variables 
genome-wide and a universe of (       
 
)              potential variable-pairs to be tested. 





dataset              , investigators who employ less stringent multiple test correction can 
use SIXPAC to discover interactions at a different cutoff as well.  
To verify that the LD-contrast statistic follows a standard normal distribution, we drew random 
variable-pairs genome-wide and constructed a QQ plot. Like others before (Liu et al. 2011), we 
observed that WTCCC data cleaning was inadequate for interaction analysis and systematically 
applied more stringent filters to preemptively screen out false positives which can be a result of 
bad genotype-calls on a few individuals. Specifically, 81085 additional SNPs which had <95% 
confidence calls (CHIAMO) in >1% of the individuals (cases and controls combined) were 
removed. For the cleaned dataset of 374,481 SNPs that remain, we verified that the LD-contrast 
statistic    ⃗⃗
    
 for randomly drawn pairs of unlinked variables >5cM apart was indeed a Z-score 
(QQ plots and additional cleaning details in 7E. ), in agreement with our null hypothesis.  
Power analysis on spiked data: Next, we tested SIXPAC's computational sensitivity by 
searching for synthetic interactions inserted into the bipolar cases while keeping the joint 
controls unchanged. 11 recessive-recessive interaction pairs between 22 SNPs on successive 
autosomal chromosomes (chr1 and chr2, chr3 and chr4, etc.) were simulated over a range of 
different parameters. Interactions between each pair of SNPs were simulated in a manner not to 
introduce and main effect, but effectively introduce only interaction effects. Details of this 
procedure are outlined in 7F.  
Algorithm 2 configures the search parameters according to two user inputs: (i) a significance 





discover all variable pairs that exceed the given significance cutoff, assuming such interactions 
exist). We tested SIXPAC on the synthetic datasets over a range of different input value 
combinations, to check whether we could discover the spiked interactions in accordance with 
theoretical estimates, and confirmed finding all of them at (or above) the power guaranteed to the 
user (0). 
Computational savings from group-sampling: To put the computational savings of our novel 
approach in context, we reviewed the literature for published, high-performance, genome-wide 
pairwise search methodologies that either (i) contrast a statistic for a pair of SNPs between cases 
and controls or (ii) directly test for statistical epistasis between a pair of SNPs using a regression 
model. Plink (Purcell et al. 2007) offers a --fast-epistasis option that tests pairs of SNPs using a 
statistic similar to ours: specifically, it collapses each pair of SNPs completely into a 2x2 table of 
major vs. minor allele counts, and subsequently contrasts the odds ratios of each combination 
between cases and controls. On the other hand, EPIBLASTER (Kam-Thong et al. 2010) operates 
on the entire 3x3 table of genotypes to contrast the exact Pearson’s correlation of each SNP-pair 
between cases and controls. Like Plink, SHEsisEPI (Hu et al. 2010) also contrasts odds-ratios of 
all SNP pairs reduced to a 2×2 table. Both EPIBLASTER and SHEsisEPI achieve speedup 
through the use of a GPU stack.  
Among the methods that directly test for statistical epistasis, we report TEAM (Zhang et al. 
2010) and FastEpistasis (Schüpbach et al. 2010). The authors of FastCHI (Zhang et al. 2009), 
FastANOVA (Zhang et al. 2008), COE (Zhang, et al. 2010) and TEAM presented a review 





datasets, and was therefore chosen to represent the family of methods. TEAM achieves 
computational speedup by a novel approach that allows it to accurately identify interacting SNP-
pairs (for most statistical tests) by checking only a small subset of individuals in the cohort. 
Unlike EPIBLASTER, Plink --fast-epistasis and SIXPAC, TEAM works directly on the logistic 
regression framework – giving it the ability to test a broader range of interaction models. The 
other method, FastEpistasis, reports epistasis in the analysis of quantitative traits (and is 
particularly built for gene-expression analysis) by implementing a rapid linear regression that 
takes advantage of multi-core processor architectures. Notable among methods omitted in this 
comparison are Multifactor Dimensionality Reduction (Ritchie et al. 2001) and Restricted 
Partition Method (Culverhouse et al. 2004), both of which partition the data according to 
genotypic effect in a relatively model agnostic manner. Consequently both methods test a variety 
of interaction models (alternate parameterizations) that are not currently captured by high-
performance computational techniques like ours and others previously discussed. Another widely 
cited method, BEAM (Zhang and Liu 2007) does not scale to present day datasets (Cordell 2009) 
and was left out of this analysis. There are numerous other methods which perform whole-
genome interaction scans (Liu et al. 2011; Emily et al. 2009; Achlioptas et al. 2011; Greene et al. 
2010; Zhang et al. 2009), and an older review of a few of these is provided elsewhere (Cordell 
2009).  
Except for SIXPAC, all the time-scales presented in  
Table 2-1 are performance figures as self-reported by the authors of each method (or in the case 





synopsis does not constitute a comprehensive methods comparison, and is presented solely to 
highlight the computational savings achieved by group-sampling. The reason SIXPAC is able to 
achieve its speedup without GPUs is because it does not need to exhaustively test all pairs of 
SNPs to identify the significant combinations
3
. On the other hand all other methods are burdened 
by a brute-force test of all pairs to identify such combinations. In confirmation of our estimates, 
they also report that genome-wide testing on ordinary CPUs requires several weeks of compute 
time (some report weeks even on a small cluster of computers). The application of group-
sampling was able to reduce this computational investment to around 8 hours. 









 Odds-ratio Contrast Brute-force Weeks No 
FastEpistasis Linear Regression Brute-force Weeks No 
TEAM Logistic Regression Check fewer individuals Weeks
6
 No 
EPIBLASTER Correlation Contrast Brute-force    day Yes (4 GPUs) 
SHEsisEPI Odds-ratio Contrast Brute-force    day Yes (2 GPUs) 
SIXPAC LD Contrast Group Sampling   hours7  No 
 
Table 2-1 Methods comparison. 
We list the approximate times reported by five other recent pairwise interaction methods (all perform an exhaustive, 
genome-wide search) to process a dataset the size of WTCCC bipolar disorder (approximately 2K cases, 3K 
controls, 450K SNPs, 1 genetic model tested per distal SNP-pair, ≈100 billion pairwise tests). For methods that do 
not use a GPU cluster, reported times were measured on a comparable desktop computer configuration to the one 
that SIXPAC was benchmarked on (Intel i7 quad core processor, 2.67Ghz with 8GB RAM). For TEAM, we 
extrapolated runtime based on performance figures reported on a smaller dataset. Graphical Processing Units 
                                                 
3
 However, we report that the SIXPAC implementation currently takes advantage of multi-core CPU architectures 
with large reserves of RAM to speed up computation, as well as cluster computing infrastructures to distribute 
computational burden across multiple nodes - all with little or no effort on the part of the end user. Details are 
provided on the software webpage.  
4
 All times as self-reported by authors of these tools, or extrapolated from performance metrics provided therein. 
5
 Operating in the --fast-epistasis mode 
6
 10K SNPs all-pairs test reported in 1000 seconds, scaling linearly with number of SNP-pairs thereon. 
7





(GPUs) are computing chips which provide around 100X speedup over regular CPUs, and were therefore used by 
two recent high-performance implementations. Despite not using such specialized hardware, SIXPAC is the only 
method which can scan a GWAS dataset of this size in a few hours. This is because while most methods effectively 
need to test each pair to find the few significant combinations, group-sampling allows SIXPAC to drastically prune 
the search space while simultaneously guaranteeing that all the statistically significant pairs will make it through 
such a pruning. 
 
Figure 2-2. Computational Efficiency.  
Our implementation of the two-stage PAC-testing framework (SIXPAC, orange line) was benchmarked on the 
cleaned WTCCC bipolar disorder dataset (approximately 2K cases, 3K controls, 450K SNPs, 4 genetic models 





universe of SNP-pairs achieved by stage 1, for each power setting. Note that unlike brute-force, this does not mean 
down-sampling the universe of SNP-pairs, but rather involves reducing the probability of identifying any one of 
them. For example, a brute-force method would presumably test 40 billion pairs (and ignore the remaining 360 
billion) to achieve 10% power on this dataset. However, PAC-testing scans all 400 billion pairs, but simply reduces 
the probability of finding the significant interactions among them to 10%. This results in shortlisting approximately 
68X fewer combinations through stage 1. Part (b) shows the efficiency of our software implementation of this 
method. We compare the performance of SIXPAC against the time taken by a brute-force approach of applying the 
LD-contrast test directly to all pairs (green line). All tests were benchmarked on a common desktop computer 
configuration (Intel i7 quad-core processor, 2.67 GHz with 8GB RAM). The last data-point shows the 90% power 
benchmarks, followed by dotted lines which illustrate how these estimates may continue as we approach 100% 
power. SIXPAC, like any randomization algorithm, will require infinite compute time to achieve 100% power, but 
can approach very close at a small fraction of the brute-force cost. Lastly, we note that these measurements only 
reflect the performance of our java program rather than what might be feasible with a different implementation of 
the algorithm. 
Novel Significant Interaction in Bipolar Disorder: We ran SIXPAC on the BD dataset with 
>95% power to check whether there exist any significant LD-contrasts between pairs of 
physically unlinked variables (SNPs >5cM apart). We report the presence of only one 
statistically significant two-locus contrast (BD cases vs. NBS+58C controls LD-contrast 
           ) between SNPs lying within two calcium channel genes : rs10925490 within 
RYR2 on chr1q43, and rs2041140 and rs2041141 within CACNA2D4 on chr12p13.33. We 
successfully replicated the signal from this region at Bonferroni significance levels in a different 
bipolar dataset of Europeans (653 BARD cases, 1034 GRU controls) from the GAIN initiative 
(Manolio et al. 2007; Smith et al. 2009; also see www.genome.gov/19518664) which were typed 
on a different platform (Affymetrix 6.0). Deeper investigation revealed that the SNP in 
CACNA2D4 is 200Kbp away from CACNA1C – a known calcium channel gene whose 
association to BD was only recently confirmed by combining large GWAS datasets for meta-
analyses (Ferreira et al. 2008; Sklar et al. 2008). Functional experiments have also confirmed the 
role played by genes at this locus in bipolar disorder (Perrier et al. 2011). Although channel 





known to play a major role in bipolar disorder, single-locus association methods were 
underpowered to implicate genes in these pathways without considerably boosting their sample 
sizes (Craddock 2007; Sklar et al. 2008; Ferreira et al. 2008). Neither gene that we report – either 
at the known locus or novel locus - was identified as a candidate by the original WTCCC 
analysis (Craddock 2007) which focused on effects visible to single-locus association. 
Specifically, we found that the dominance variable of rs10925490 (one or more minor alleles) 
was in severe positive linkage disequilibrium with the recessive variables of adjacent SNPs 
rs2041140 and rs2041141 (two minor alleles each) in BD cases, and slight negative 
disequilibrium with them in controls, giving an LD-contrast            . To verify that this 
signal was not due to any unaccounted biases, we first confirmed that high LD between the two 
variables was specific to BD cases only, even when contrasted against samples from all other 
WTCCC disease phenotypes (6 tests of BD vs. other-disease-cases all show LD-contrast 
      ).  Next, we performed a permutation analysis to characterize the empirical distribution 
of the LD-contrasts statistic at the theoretical significance level of             (i.e. to check 
if                ). We ran SIXPAC on 100 phenotype permuted versions of the same dataset 
(i.e. 100 whole-genome, all-pairs scans for interaction) and observed             between a 
pair of SNPs in only 1 such permutation (               ). 
Finally, we sought to replicate the observed difference in LD at these loci. In the GAIN dataset, 
we considered all LD-contrasts in an area of   SNP immediately upstream and downstream of 
rs10925490 in the dominant allelic mode, against   SNP immediately upstream and downstream 





and including the original interaction), to test if any pair in this area bore an LD-contrast that 
passed the conservative Bonferroni significance cutoff   
    
 
      . This roughly translates 
to a region   Kbp upstream and downstream of each SNP in the original pair. Although there 
was no appreciable difference in LD between the same SNPs (rs2041140/rs10925490 shows LD-
contrast       ), we observed a significant LD-contrast            between rs2041140 
and rs677730 (the SNP immediately upstream of rs10925490 on the Affymetrix 6.0 platform). 
To confirm that this observation was not likely by chance, we randomly picked 5000 pairs of 
physically unlinked (>5cM apart) SNPs genome-wide and tested an equal neighborhood of     
LD-contrasts around each pair in the GAIN dataset. Only 1 out of 5000 random areas contained a 






Figure 2-3 Bipolar Disorder Interaction. 
In a genome-wide scan of all 400 billion variable-pairs (4 genetic models tested per SNP-pair) in the WTCCC 
bipolar disorder dataset (Affymetrix 500K), SIXPAC found one significant interaction               between 
SNPs >5cM apart that satisfied all our filtering criteria. The SNPs rs10925490 and rs2041140 lie within the RYR2 
gene on chr1q43 and the CACNA2D4 gene on chr12p13.33 respectively. Each figure shows the -log(pvalue) from a 
standard single-locus association test (allelic model) of the two SNPs as well as 25 SNPs immediately upstream and 
downstream from each of them, along the X and Y axis. Also shown in the grayscale area is the –log(p) from the 
pairwise LD-contrast test of all            variable-pairs. As suggested by the original finding, SNPs around 
rs10925490 were considered in dominant allelic mode, while SNPs around rs2041140 were in recessive mode. We 
replicated this signal by similarly testing      dominant-recessive pairs of variables around the very same SNPs in 
a much smaller bipolar disorder dataset from the GAIN consortium (Affymetrix 6.0). In the replication dataset, we 
observe several pairs that cross the significance threshold and a strikingly similar visual pattern in the LD-contrast 
landscape (see main text for a permutation analysis). The top pair (rs677730- rs11062012) in this area is pinpointed 
with dashed lines (see main text for permutation analysis). Standard single-locus association analysis does not yield 
any significant result in either dataset, as seen in the marginal Manhattan plots (gray dashed line represents genome-
wide significance level). 
 
To get a better picture of the LD-contrast landscape between SNPs in this region, we conducted a 
wider survey of the area spanning     SNPs (upstream, downstream and including) both 





SNPs that show differences in LD going in the same direction (strong LD in cases, weak 
negative LD in controls) – arranged in a strikingly similar pattern in both datasets, presenting 
strong evidence of an inter-locus effect. The 2 dimensional LD-contrast spectrum for this larger 
area is presented in Figure 2-3, alongside the Manhattan plots for marginal association at each 
locus. The top SNP-pair in the area (rs677730,dom × rs11062012,rec) had LD-contrast   
          in GAIN: a similar phenotype permutation analysis as earlier reveals that only 19 
out of the 5000 randomly chosen       areas genome-wide contained a more significant pair 
                   . It can also be seen that there is no marginally significant association at 
these loci  in either dataset.  
 
 
Table 2-2 presents a summary of the results along with the single most significant variable pair 
in the larger test area for each dataset.  
Dataset 
















WTCCC rs10925490, d 0.5974 rs2041140, r 0.6594           4.61e-14 1.28e-09 
GAIN rs677730, d 0.17 rs11062012, r 0.05           1.19e-06 0.0001 
 
Table 2-2. Bipolar Disorder Interaction.  
The lower table lists the most significant LD-contrast SNP-pair spanning two calcium channel genes RYR2 and 
CACNA2D4, in both the original (WTCCC) as well as the replication datasets (GAIN). Columns 2 and 3 present the 
apparent mode of action for this SNP-pair (represented as SNP rsid, allelic mode – dominant d, recessive r), and the 

















cases and controls (each normalized into a Z-score), which are derived by comparing the expected to the observed 
co-carriers in cases and controls (see boxes below). These counts are outlined in the tables above, and show a clear 
enrichment of observed minor allele co-carriers in cases and depletion in controls (against their corresponding null 
expectations, assuming linkage equilibrium). Column 5 reports the LD-contrast significance (note that the LD-
contrast statistic is not a simple difference in Z-scores). Although LD-contrast does not seek or imply statistical 
epistasis, we can see that the pair is also a nominally significant candidate as per a logistic regression based 1 d.f. 
test for interaction term, as shown in column 6. 
2D. Discussion 
In this work we introduced a novel method that defuses the computational challenge of a genome 
× genome interaction scan by using the statistical constraint towards, rather than against our goal. 
Focusing only on interactions that have a chance of achieving statistically significant association, 
we developed a rapid filter that does not require the naïve arduous scan of all pairs of variants. 
To demonstrate its utility, we implemented an established test for interaction which contrasts LD 
between cases and controls, to demonstrate how an exhaustive genome-wide multi-locus 
association search is possible while saving an order of magnitude or more in computational 
resources. Usefully, we are also able to provide performance guarantees and quantify the 
approximate nature of our output, and our algorithm brings genome-wide three-locus scans into 
the realm of feasibility.  
While the focus of this contribution is computational methodology, we prove applicability in 
practice to a classical GWAS dataset. Among widely investigated common diseases, bipolar 
disorder remains one of the most recalcitrant phenotypes to GWAS methodology (Craddock and 
Sklar 2009), perhaps in part because of the limitations of single locus association analysis. We 
highlight the power and utility of multi-locus effects in terms of uncovering molecular processes 





discoveries that were only made possible through a significant increase in dataset size.  We have 
replicated this observation in an independent dataset, strongly suggesting a bona-fide underlying 
interaction between members of a gene-family known to be functionally associated with bipolar 
disorder, making it suitable for further investigation.  
Compared to the number of single-locus associations, GWAS of common phenotypes in humans 
have uncovered very few reproducible gene-gene effects so far. This is partly because interaction 
analyses for human populations are difficult to design and interpret (Cordell 2002; Phillips 
2008). A conventional test for statistical epistasis is expected to only identify loci whose 
combined effect on phenotype is not explained by the addition of their individual effects, for an 
appropriately chosen scale. In case-control studies, this typically involve applying a logistic 
regression to check for significance of the interaction term(s) after accounting for main effects 
(Wang et al. 2010): which is equivalent to a test for deviation from multiplicative odds (or 
additive log-odds). However, there are several limitations to this approach – scale of choice 
(Mani et al. 2008), assumption of a genetic model by which two-loci combine their effects 
(Hallander and Waldmann 2007), limited models of interaction that can be tested (Li and Reich 
1999; Hallgrímsdóttir and Yuster 2008) and limited sensitivity of logistic regression to non-
normal residuals, among others. How these factors might cumulatively affect a test for other 
models of genetic interaction has not yet been decisively established.  
Further, true biological interaction between two or more loci may or may not manifest itself as a 
departure from additivity. Two loci whose main effects appear to combine in an additive manner 





disease (Wang et al. 2011). In general, two-locus association tests are known to contribute signal 
independent from what is seen by conventional single locus association tests (Kim et al. 2010; 
Marchini et al. 2005) and comprehensive multi-locus association strategies may be worth 
undertaking despite the increased multiple testing burden (Evans et al. 2006a). Indeed, recent 
work (Zuk et al. 2012) showing that alternate models of biological interaction could confound 
estimates of heritability have redirected the attention of the genetics community on the potential 
of interaction studies. 
A previous genome-wide scan for statistical epistasis on the same bipolar disorder dataset had 
reported Bonferroni significant epistasis between rs10124883 and four other SNPs (Hu et al. 
2010). As expected, all four pairs approached (but did not clear) Bonferroni significance levels 
as per the LD-contrast test as well           – and could therefore be captured simply by 
lowering the significance cutoff. This congruence between tests for statistical epistasis and 
contrast tests has been exploited by others (Plink, EPIBLASTER) and indeed, also holds for the 
binary LD-contrast test (see tables in 7F. ). But whereas other methods would employ a brute-
force testing strategy to identify candidate SNP-pairs, PAC testing will accomplish the same 
result much quicker by looking at a small fraction of the pairs.  
Our findings do suggest that unlike stepwise regression approaches that sequentially attribute 
residual variance/deviance to each of their components, tests that make fewer assumptions 
regarding scale may indeed be more powerful at capturing a wider range of interactions. 
Conversely, a distinct advantage of regression over our LD-contrast test remains its clear 





controls is consistent and reproducible across datasets, it does not immediately suggest a clear 
causal genetic model underlying this signal. We dissected this interaction using the standard 
logistic regression,    
 
   
                    , where          codes for dominance 
carrier status at rs10925490 while    codes for recessive carrier status at rs2041140. The main 
effects        were observed to be not significant, while the epistasis term     was considerable 
(      ), suggesting deviation from multiplicative odds is one option. We also considered the 
standard full genotype model (0/1/2 parameterization of predictor variables) with 8 degrees of 
freedom (Cordell and Clayton 2002) as implemented by INTERSNP (Herold et al. 2009), where 
the most significant test (Test 6,        ) was the one comparing the full model against a 
model that accounts for just within-SNP additive and dominance effects. In a genome-wide 
search for interaction using logistic regression, these levels are likely  to fall short of significance 
cutoffs after correcting for hundreds of billions of tests performed: which explains why other 
methods seeking statistical epistasis on the same BD dataset did not report LD between the 
RYR2-CACNA2D4 as a significant finding. A true etiological understanding of this persistent 
difference in LD may require sequencing at each locus to identify the interacting variants.  
Results in other WTCCC datasets: Subsequent to the publication of the original paper (Prabhu 
and Pe’er 2012b), SIXPAC was extended to implement the LOD-contrast statistic (discussed in 
section 7K. ). Unlike LD-contrast, contrasting log of odds exposes interaction as measured on its  
most widely adopted scale: logistic regression. When we ran SIXPAC on the 6 other phenotypes 
collected by the WTCCC (Crohn’s disease, Coronary Artery disease, Type I and Type 2 





at        . In the absence of replication datasets, it is unadvisable to apply the more powerful 
LD-contrast test which tends to suffer from an inflated type I error rate. 
Limitations and Extensions: The major contribution of this work is a computational technique to 
rapidly identify SNP-pairs with  large values of a test statistic without performing a brute-force 
search. While we assessed the issue of power with regards to our randomization algorithm, we 
left the separate (but equally important) concept of statistical power unaddressed – i.e. the ability 
of an interaction test to spot a true biological interaction in the dataset. Although contrasting LD, 
correlation and odds-ratios between cases and controls have all separately been characterized as 
powerful tests for interaction, each test makes specific model assumptions and is powerful only 
under its own regime. Consequently, the absence of interaction reported by SIXPAC (or indeed, 
by any other software) does not imply the absence of interaction itself, but could simply mean 
lack of statistical power of the test, inadequate number of samples, or simply, incorrect model 
assumptions. During the course of publishing this method, minor corrections were suggested for 
a range of contrast statistics to improve their power and decrease type I error rate (Ueki and 
Cordell 2012). Again, we note that modifications to these tests can be easily adopted into our 
computational methods – which are agnostic of statistics. 
In contrast to the performance gains offered by group-sampling are its two notable weaknesses. 
First - like any other randomization algorithm - group-sampling can never achieve 100% power 
(probability of completion), whereas brute-force approaches will. Second, by virtue of limiting 
itself to binary features, testing for genetic models that incorporate allelic dosage and trend 





computational principles to implement rapid correlation and odds-ratio contrast tests (among 
others) may be appealing, the loss of statistical power from increasing the number of tests is less 
easily addressed.  Where we currently encode recessive and dominance binary status, each 
additional test may require a different encoding of features (genotypes, or combinations thereof), 
thereby adding to the multiple testing burden. Overcoming these limitations appears non-trivial, 
and increases in sample size will almost certainly play a crucial role in discovering these hidden 
genetic connections.  
Extrapolating from the hardware speedups reported by others (Kam-Thong et al. 2010; Hu et al. 
2010)  may suggest that a high-performance GPU-enabled implementation of  our method might 
offer a scan of all-pairwise interactions in a few minutes, and all 3-way interactions on the order 
of a day(s) in large GWAS datasets. But a more immediate concern related to testing 3-way 
interactions would be the statistical power and semantic interpretation of such a test (conceivably 
devised on a 2×2×2 binary table). In conclusion, we note that while the transition of association 
studies from SNP arrays to full ascertainment of variants may have led to analytical emphasis on 
rarer alleles, it has only increased the impetus to examine the spectrum of multi-locus effects. 
With so many more variants to consider, the computational limitations will only become more 





Chapter 3. Functional enrichment of SNP-SNP interactions 
3A. Background 
Over the past two decades, genome-wide linkage and association mapping methods have 
investigated millions of genetic markers (Hindorff et al. 2009; GWAS catalog), predominantly 
SNPs, and implicated a few thousand of these underlying a wide range of disease phenotypes. 
Importantly, these associations can help us better understand the genetic architecture of these 
heritable traits, bringing us closer to treatment and prevention. Although these genome-wide 
significant findings have helped us make some crucial insights into the biology of these 
phenotypes, they cumulatively capture only a fraction of the total genetic signal underlying their 
respective traits. For most common diseases, a large part of the genetic variance remains 
unexplained, suggesting that most of the loci and mechanisms underlying disease are yet to be 
discovered (Maher 2008). 
In this regard, pathway-based association methods that utilize functional information ascribed to 
various loci on the genome have been tremendously useful. Instead of looking at SNPs in 
isolation, these methods typically group SNPs by functional annotation, devise statistics to 
measure each group’s  significance from its constituent  SNPs, and then test which groups 
contain a significantly greater number of highly associated SNPs than others. This general 
approach has developed well-established statistical principles and has been implemented by a 
wide variety of methods (Holmans et al. 2009; Mootha et al. 2003; Miao-Xin Li et al. 2011; 





from SNPs well below genome-wide significance levels can be utilized – and this strategy that 
has borne high returns.  
In this work we present a pipeline that takes this idea a step further. We consider a framework 
that allows us to test for enrichment in interacting SNPs across a pair of functional groups, as 
opposed to marginally associated SNPs in a single group. Specifically, we determine all epistatic 
(non-additive) effects between pairs of SNPs straddling two functional groups (where each SNP 
in the pair belongs to one group) and ask whether there is any overall inflation in the level of 
epistasis between these two groups. Mechanistically, we extend single-group enrichment 
methods in a relatively straightforward manner but use recent, high-speed genome-wide 
interaction methods that make this experiment computationally feasible.  
In this paper, we consider functional groups for human genes defined by the Gene Ontology 
database (Ashburner et al. 2000). The goal of this work is to find whether there is any evidence 
of ontology-ontology epistasis underlying common disease. By definition, statistical epistasis 
between two SNPs suggests that their combined effect deviates from what one would expect if 
each SNP acted independently of the other (there are several excellent references that discuss 
types, causes, scales and interpretation of epistasis (Cordell 2002; Cordell 2009; Wang et al. 
2010; Moore and Williams 2009)). Under the most widely accepted definition of independence 
for dichotomous phenotypes, the effect of two genetic features on phenotype status is expected to 
be additive. In case versus control genome-wide association studies, this typically entails 
applying a logistic regression to find pairs of SNPs whose combined effect deviates from the 





connectivity between the two loci and can potentially help us make useful insights into the trait’s 
genetic architecture. By extension then, evidence of increased epistasis between two ontologies 
(if it indeed exists) can offer a broader view into whether certain functional groups are more 
closely intertwined than others in the context of a disease’s etiology.  
A major concern for such an experiment is the massive computational investment required by a 
genome-wide epistasis scan. Until recently, the burden of even a single genome-wide scan of 
         SNP-pairs (assuming a contemporary assay        SNPs)  required in a brute-force 
approach was justly considered to be quite computationally expensive (Marchini et al. 2005). 
Furthermore, to establish the significance of an ontology-pair in a robust empirical manner, it is 
conceivable that we will have to undertake such a scan not just once but several thousand times 
under a permutation testing scheme. The computational impracticality of such an effort has 
necessitated several simplifying assumptions by earlier analyses (Emily et al. 2009b; Hannum et 
al. 2009). Principal among these assumptions is that certain SNPs are more important than others 
– where “importance” was measured by a high marginal association score, or by whether the 
SNP lies in the exome, or causes an amino acid change, or some other inferred biological 
motivation – and such SNPs may therefore be preselected. Subsequently, pairwise interaction 
scans were restricted test the chosen candidates. Even so, these early semi-exhaustive 
experiments for functional enrichment of pathway pairs using SNP interaction signatures have 
been tremendously successful at identifying pathway and protein complex interaction signatures. 
Although these assumptions made functional enrichment experiments practical, their findings 
only provide a partial picture of the epistatic landscape. It is well known that epistasis between 





on our (presently) incomplete understanding of genome biology can cause statistical biases 
(Evans et al. 2006; Marchini et al. 2005). In light of this, an unbiased and exhaustive genome-
wide analysis merits consideration.  
The publication of several of rapid genome-wide SNP-SNP interaction mapping tools (Prabhu 
and Pe’er 2012; Zhang et al. 2010; Kam-Thong et al. 2010; Hu et al. 2010; Schüpbach et al. 
2010) have made functional interaction enrichment an attractive and viable proposition. In this 
work, we use SIXPAC (Prabhu and Pe’er 2012a), a tool developed by our group, for its speed 
and robustness. However, the principles of the subsequent analysis pipeline and associated 
software can be applied in conjunction with any of the other methods. We applied our method to 
Wellcome Trust Bipolar Disorder dataset (Craddock 2007) to find compelling evidence for 
pervasive interaction between biological relevant gene groups.  
The rest of this paper is structured as follows. First, we describe in detail the functional 
enrichment pipeline and the methodological modifications required to parse through an input list 
of SNP-SNP associations (in place of SNP associations). Subsequently, we describe the results 
of our analysis on Bipolar Disorder dataset. In conclusion, we discuss our findings and suggest 







Functional enrichment methodology is considerably mature, and here we list a few best-practices 
that have become established in the literature. First, SNPs within a physical window (usually 
20Kbp to 50kbp) of a gene’s boundaries to that gene (Holmans et al. 2009; Li et al. 2011). Note 
that this definition allows for a single SNP to be assigned to multiple genes. To derive a gene’s 
association score from its SNPs, various schemes such as choosing the minimum, mean, and 
average top percentile of p-values of each gene’s constituent SNPs have been explored (Lehne et 
al. 2011). Subsequently, to derive an ontology enrichment score, the most widely used approach 
is to apply a running sum statistic like Kolmogorov-Smirnov (KS) on a list of gene scores in 
each ontology (Subramanian et al. 2005; Mootha et al. 2003) . Intuitively, the KS statistic is a  
measure of the overall inflation in gene scores within the ontology against a background of gene-
scores that are not. To account for potential statistical biases like variation in number of tests 
(SNPs per gene, as well as genes per ontology), normalization procedures are used to adjust the 
statistics. Further biases that can skew statistical scores are due to LD between SNPs in a gene 
(resulting in non-independence of tests) or genes in an ontology (due to clustering of genes 
belonging to certain functional groups) are the most difficult to correct analytically (Holmans et 
al. 2009). Consequently, the most reliable and statistically robust way to account for such biases 
is through permutation testing. Deriving an empirical null distribution of the enrichment score 
for each ontology provides us with the most unbiased estimate of its significance. 
We systematically extend the principles gleaned from functional enrichment on single-locus 





where each SNP in the pair is assigned to one gene of the pair. For example, to derive an 
association score for a pair of genes     (with   and   distinct SNPs respectively), we consider 
the sorted list of p-values              for all SNP-pairs
8
. We then apply the Simes 
multiple-test correction procedure on this list:  
    
         
   





This is less conservative and more powerful multiple test correction than the family wise error 
rate (FWER) control procedures like the Bonferroni, particularly when the multiple hypotheses 
tested are not independent of each other (i.e. correlated tests), as in our case [\cite]. Unlike 
Bonferroni, the Simes procedure gives us a p-value for all the    null hypotheses tested being 
true simultaneously, and does not try to control for a false positive rate.  
Analogously, to devise an association score for an ontology-pair, we consider all those gene-
pairs where one gene belongs to one ontology and the other to the other. For example, to derive 
an enrichment score       for a pair of ontologies     (with   and   distinct genes 
respectively), we consider the sorted list of Simes corrected p-values for all gene-pairs     
         and apply the standard Kolmogorov-Smirnov statistic. 
                                                 
8
 If, on the other hand, genes   and    contain   SNPs in common as a result of their proximity, then we only 
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where   ( 
 
) is the size of the gene-pair universe if we consider   genes, and   is the cutoff at 
which the KS statistic is maximized. The statistic captures the difference in proportion of gene-
pairs with a score below   that belong to the ontology-pair and gene-pairs that do not. We extend 
our earlier caveat to subsume ontologies which have genes in common by ignoring any gene-
pairs where both genes are the same (i.e. we do not consider the case of a gene interacting with 
itself just because it belongs to both ontologies). 
As input, a genome-wide scan for epistasis is used to provide a list of p-values for each SNP-
pair. In this work, we employed SIXPAC for its speed and completeness. SIXPAC now provides 
an implementation of the LOD-contrast statistic (Ueki and Cordell 2012; Wu et al. 2010), which 
is equivalent to testing for epistasis using the traditional logistic regression method but is 
computationally much faster. In other words, the p-value for each SNP-pair is the same as the p-
value one would obtain by testing the interaction term in a logistic regression. Details are 
provided in the section 0 
From the list of SNP-pair p-values, gene-pair p-values and subsequently ontology-pair KS scores 
can be calculated. The significance of an ontology-pair KS score is calculated through a 





SNP-pair epistasis, and repeat the procedure to compute a KS score under permutation. This is a 
computationally intensive task that is made feasible by the speed of SIXPAC. We perform five 
thousand permutations (genome-wide, exhaustive SNP-pair interaction scans) to derive an 
empirical assessment of the null distribution of enrichment scores. 
At the ontology-pair level as well, FWER corrections like Bonferroni can be too conservative 
and  impractical. For example, assuming just 1000 ontologies of interest, and consequently 
(    
 
) ontology-pairs, achieving Bonferroni significance at        would require around 10 
million permutations. In light of this computational impasse, we describe a different technique to 
control for experiment wide false discovery rate.  
Firstly, just as we accounted for variation in SNPs per gene in the gene-pair p-value, we need to 
incorporate variation in ontology size into the enrichment score. An elegant technique has been 
described in (Wang et al. 2007). Given an observed enrichment score       for a pathway-pair 
   , its normalized enrichment score is calculated as  
       
                    
            
 
Equation 3-3 
where          represents the enrichment score for   
  under phenotype permutation  . 
Subsequently, we say the proportion of false discoveries     to true positives       at any 





     
 
     
 
                 
                   
 
                                 
 
Equation 3-4 
Since we are interested in results that are highly likely to be real, we apply a stringent threshold 
of           on our findings. We have implemented this method in a java software package 
called FUNGI (Functional enrichment of genetic interactions). 
 
Figure 3-1 Functional enrichment pipeline.  







We applied our method (pipeline illustrated in Figure 3-1) to the Bipolar Disorder (BD) dataset 
provided by the Wellcome Trust Case Control Consortium (WTCCC). The data consists of 
around 2000 cases and 3000 controls (combined from the 1958 birth cohort and National Blood 
Service), all typed on the Affymetrix 5.0 assay. To alleviate the risks of false positives due to 
batch effect, population structure and other experimental bias, in addition to prescribed cleaning 
(Craddock 2007) we further subjected the data to extremely stringent filters (see section 7E. ), 
leaving us with a cleaned dataset of 370234 SNPs genome-wide in 2881 controls and 1818 cases.  
Next, we discarded autosomal SNPs that do not reside within the genes, leaving us with 113626 
genic SNPs. These are defined as lying within a 50Kbp window around gene boundaries (Kbp 
window used to cover proximal promoter and enhancer sites). Gene start and end coordinates 
were obtained from UCSC genome browser the March 2006/hg18 reference build and are those 
used by the WTCCC dataset. Functional annotations for homo sapiens genes were downloaded 
from the curated GO database (Ashburner et al. 2000), release 01/21/2013. Ontologies that were 
too general (>1000 genes) or too specific (<5 genes) in their definition were discarded for their 
limited utility and also to alleviate the multiple testing burden. Since our experiment hinges on a 
permutation testing scheme, the effect of any other source of confounding (such as overlapping 
ontologies, redundant definitions, etc.) on type 1 error is minimized. 
As described in pipeline (see methods, figure 1), we first performed an exhaustive SIXPAC 
search on BD cases vs. controls to find     SNP-pairs that demonstrate epistasis at       . 





details and explanation). We then applied SIXPAC with the same search parameters on 5000 
phenotype permuted versions of this dataset to make an equivalent  list of epistatic SNP-pairs for 
each one, giving us a background of           SNP-pairs discovered on average. This suggests 
that there may be nothing remarkable about the overall number of epistatic interactions between 
genic SNPs, assuming our data had sufficient statistical power to find all bona-fide interactions 
at        or that this estimate holds as sample sizes increase. This is also in accord with the 
lack of reported and robustly replicated interactions at Bonferroni significance levels on GWAS 
datasets so far.   
The objective of this work is to group epistatic SNP-pairs according to their annotations and 
check whether there is anything notable about the case vs. control hits – if not in their number, 
then perhaps in their location and functional characterization. We ran the FUNGI pipeline on the 
observed and permuted datasets to find just 157 interacting ontology-pairs (edge) between 110 
ontologies (nodes) at a false discovery rate of          , as illustrated by the graph in Figure 
3-2. The complete graph (not shown) contains 17 connected components, the ranging from a 
large dense cluster (25 nodes, 78 edges) to several small single edge cliques. The largest cluster 
is also the most intriguing, as it contains the most highly-connected ontologies (gene groups 
comprising the trans-membrane receptor protein serine/threonine kinase signaling pathway, LDL 


















Figure 3-2 Graph of ontology interactions.  
Clusters 1 to 4. Full graph not shown. 
Interestingly, the serine/threonine pathway is also the target of the most widely prescribed 
compound for Bipolar Disorder – Lithium (Machado-Vieira et al. 2009; Chalecka-Franaszek and 
Chuang 1999; Hall et al. 2002; Tsuji et al. 2003). The role of lipid levels in pathophysiology has 
also been well documented, both in Bipolar Disorder and Schizophrenia (Ghaemi et al. 2000; 
Chung et al. 2007; Vila-Rodriguez et al. 2011).  
The second largest cluster highlights the role of cerebellar Purkinje cells which have been 
implicated in a variety of psychiatric disorders, including mood disorders like schizophrenia and 
depression (Tsai et al. 2012; Maloku et al. 2010; Lingärde et al. 2000; Tran et al. 1998). The 
third and fourth clusters are isomorphic and show a hub-spoke pattern. Cluster 3 outlines the role 
of histidine catabolism: histidine is an amino acid precursor to histamine, a major 
neurotransmitter widely studied in psychiatric phenotypes (Ruitenbeek et al. 2009; Nuutinen and 
Panula 2010; Jin et al. 2009). Cluster 4 elucidates a known inter-connections between genes 
involved with tropomysin and actin filaments, groups have a known role in muscle disease, but 
whose role is less understood in this context. Interestingly, new drugs are being developed to 







Over the past few years, advances in computational and statistical methodology in conjunction 
with increases in sample sizes                      and assay resolution              have 
made it feasible to map genetic interactions in human populations. Despite this, few robust 
genome-wide significant interactions have been reported in common disease datasets. More 
pertinently, the findings present insufficient evidence to resolve the hotly debated question of 
whether interactions are pervasive (Zuk et al. 2012) or anecdotal (Hill et al. 2008) in human 
genetics, and how much genetic variance they might cumulatively explain.  
In this work, we attempted to characterize the functional interaction landscape of a widely 
studied common disease with a large genetic component and one of the highest heritability 
estimates among psycho-affective disorders in europeans (      , McGuffin et al. 2003; 
Edvardsen et al. 2008). To do so, we implemented a well-established but hitherto 
computationally impractical functional enrichment pipeline. We limited our models to a list 
epistatic interactions: defined as deviation from additive log of odds in a logistic regression. As a 
caveat, we note that though the logistic scale is the most widely used (interaction on this scale is 
commonly referred to as statistical epistasis, as per the original Fisherian definition (Fisher 
1918)), it is by no means the only one (Cordell 2009). It remains to be seen whether other 






Our minor result is that the number of such interactions between genic-SNPs when comparing 
bipolar cases to healthy controls does not appear to be any different than what one would expect 
by chance. Our major result is that by integrating functional information associated with these 
interacting loci, a clear picture of interaction between elements of biologically and clinically 
relevant pathways arises. 
To the best of our knowledge, this work describes the first tractable approach to a rigorous, 
unbiased and genome-wide assessment of ontology-ontology epistasis in human genetic datasets. 
While previous methods severely restricted their search space in the interest of computational 
practicality, our work attempts a more exhaustive scan, made possible by the speed of recent 
interaction methods. In particular, we were able to apply rigorous permutation testing to establish 
the empirical significance of our results in a computationally feasible manner, rather than relying 
on analytical methods that often rely on scale-limit approximations and sample homogeneity. By 
deriving an empirical null distribution for the enrichment statistic, our permutation design 
implicitly corrects for any subtle biases that might be introduced by confounders like linkage 
disequilibrium and population stratification. This is all the more important on large GWAS 
datasets like WTCCC, where data can be collected from multiple centers and represent several 
sub-populations that are often processed separately. 
In conclusion, we note that though our method offers a broader picture of the epistatic landscape 
underlying a common disease than those before us, our study is currently limited to the genic 
region of the genome. Recent advances in genome annotation, particularly those made by the 





and more expressive range of interacting functions. However, the endeavor is not as 
straightforward as it first seems : a drastic increase in the number of annotations means a 
concomitant increase in the multiple-testing burden. Given that our experiment was designed to 
overcome the very issue of low statistical power in genome-wide interaction scans in the first 
place, this can appear self-defeating in outcome. Careful thought needs to be given to tradeoffs 
between statistical power and the number and specificity of annotations. Lastly, increasing the 
coverage of function from genes to the whole genome, would mean     increase in number of 
SNPs, and     corresponding increase in the number of pairwise SNP interactions to be tested 
by each permutation. Considering that we will also have to test a larger number of function pairs, 
the overall experiment will be even more computationally expensive than our current pipeline. 
In the past, several theoretical models had predicted that under the expected realm of small effect 
sizes, finding epistatic interactions would require tremendous increases in statistical power – 
presumably by collecting larger and larger cohorts (Evans et al. 2006a; Zuk et al. 2012). Today, 
our results offer additional evidence that epistasis is both pervasive and is a relevant mechanism 
of pathogenesis.  However, rather than trying to map isolated events of SNP-SNP interaction – 
an approach that is almost always pathologically underpowered – pursuing alternate strategies to 
characterize broad patterns of interaction between biologically meaningful genomic elements 





Chapter 4. Cost-effective DNA sequencing for large cohorts. 
Summary: Resequencing genomic DNA from pools of individuals is an effective strategy to 
detect new variants in targeted regions and compare them between cases and controls. There are 
numerous ways to assign individuals to the pools on which they are to be sequenced. The naïve, 
disjoint pooling scheme (many individuals to one pool) in predominant use today offers insight 
into allele frequencies, but does not offer the identity of an allele carrier. We present a 
framework for overlapping pool design, where each individual sample is resequenced in several 
pools (many individuals to many pools). Upon discovering a variant, the set of pools where this 
variant is observed reveals the identity of its carrier. We formalize the mathematical framework 
for such pool designs and list the requirements from such designs. We specifically address three 
practical concerns for pooled resequencing designs: (1) false-positives due to errors introduced 
during amplification and sequencing; (2) false-negatives due to under-sampling particular alleles 
aggravated by non-uniform coverage; and consequently, (3) ambiguous identification of 
individual carriers in the presence of errors. We build on theory of error-correcting codes to 
design pools that overcome these pitfalls. We show that in practical parameters of resequencing 
studies, our designs guarantee high probability of unambiguous singleton carrier identification 
while maintaining the features of naïve pools in terms of sensitivity, specificity, and the ability to 
estimate allele frequencies. We demonstrate the ability of our designs in extracting rare 






DNA sequencing is being revolutionized by new technologies, replacing the methods of the past 
decade. “Second generation” sequencing currently offers several orders of magnitude better 
throughput at the same cost by massively parallel reading of short ends of genomic fragments 
(Mardis 2008). This enables addressing new questions in genomics, but poses novel technical 
challenges. Specifically, it is now feasible to obtain reliable genomic sequence along a 
considerable fraction of the human genome, from multiple individual samples. Such high-
throughput resequencing experiments hold the promise of shifting the paradigm of human 
variation analysis and are the focus of this study.  
Connections between genetic and phenotypic variation have traditionally been studied by 
determining the genotype of prescribed markers. This cost-effective strategy for large-scale 
analysis has recently led to multiple successes in detecting trait-associated alleles in humans 
(Wang 1998; Risch 2000). However, genotyping technologies have two fundamental drawbacks: 
First, they are limited to a subset of segregating variants that are predetermined and prioritized 
for typing; second, this subset requires the variant to have been previously discovered in the 
small number of individuals sequenced to date. Both of these limitations are biased toward 
typing of common alleles, present in at least 5% of the population. Such alleles have been well 
characterized by the Human Haplotype Map (The International Hapmap Project, 2003) have 
been associated with multiple phenotypes. On the other hand, rare alleles are both under-
prioritized for association studies, and a large fraction of them remain undiscovered (Reich et al. 





Resequencing can fill in the last pieces of the puzzle by allowing us to discover these rare 
variants and type them. Particularly, regions around loci that have previously been established or 
suspected for involvement in disease can be resequenced across a large population to seek 
variation. However, finding rare variation requires the resequencing of hundreds of individuals: 
something considered infeasible until now. With the arrival of low-cost, high-fidelity, and high-
throughput resequencing technology, however, this search is feasible, albeit expensive. At the 
time of this work, Illumina's Genome Analyzer (Gunderson et al. 2004), ABI's SOLiD sequencer 
(Fu et. al., 2007), 454 Life Sciences' (Roche) Genome Sequencer FLX  (Margulies et al. 2005), 
to name a few, were the primary technology providers offering throughputs on the order of giga-
base pairs in a single run (Elaine R Mardis 2008).  
Resequencing is typically done on targeted regions rather than the whole genome, making 
throughput requirements to sequence an individual much less than what is provided by a single 
run. A costly option is to utilize one run per individual, but in a study population of hundreds or 
thousands, such an approach is prohibitively expensive. In such cases, “pooled” sequence runs 
may be used.  
The central idea of pooling is to assay DNA from several individuals together on a single 
sequence run. Pooled Genotyping has been used to quantify previously identified variations and 
study allele frequency distributions (Shaw et al. 1998; Ito et al. 2003; Zeng and D Y Lin 2005) in 
populations. Given an observed number of alleles and an estimate of the number of times an 
allelic region was sampled in the pool, it is possible to infer the frequency of the allele in the 





the added advantage of being able to identify new alleles. At least one recent work has analyzed 
the efficacy of pooled resequencing for complete sequence reconstruction (Hajirasouliha et al. 
2008). The investigators of that work studied the problem of reconstructing multiple disjoint 
regions of a single genome while minimizing overlap between regions. Our work addresses the 
problem of identifying rare variations contained within a single region across multiple 
individuals.  
Historically, the primary trade-off of a pooled approach has been the inability to pinpoint the 
variant carrier from among the individuals sequenced in a pool. Retracing an observed variant 
back to its carrier required additional sequencing (or genotyping) of all of these individuals, one 
at a time. Barcoding is an upcoming experimental method that involves ligating a “signature” 
nucleotide string (∼5 bp) to the start of all reads belonging to an individual. These nucleotides 
serve as the barcode that identifies which individual a given sequenced read came from. If/when 
established, barcoding technology may essentially offer a more complex assay for a wet-lab 
solution to the same problem we address through computational means. Other purely 
computational approaches to pooled sequencing have arisen from the fields of group testing and 
compress sensing (Ding-Zhu Du and Hwang 1993; Margraf et al. 2011; Erlich et al. 2009). In 
our work, we focus purely on the application of computer coding theory to this problem. 
The rest of this chapter is organized as follows: in the Methods section, we first introduce a 
generic mathematical model that can be used to represent the pooled resequencing process. We 
develop figures of merit to evaluate a pool design's robustness to error, and coverage under given 





designs and error-correcting designs. In the Results section we compare the efficacies of our 
designs against each other and against current practices using synthetic data as well as real short-
read data from the 1000 Genomes Pilot 3 project (www.1000genomes.org), where we quantify 
the abilities and trade-offs of the designs in the context of various sources of noise.  
4B. Methods 
A resequencing experiment is characterized by the target region and a cohort. We consider a 
cohort             of   diploid individuals. These individuals are to be sequenced for a target 
region of   base pairs using   pools (or sequence runs) labeled            . Each pool offers 
a sequencing throughput of   base pairs mapped to the reference sequence. A key factor in such 
an experiment is the mean expected coverage of diploid individuals in the cohort. This is the 
number of reads  ̂ in which each haploid nucleotide of that individual is expected to be 
observed, summed over all pools, and averaged over all individuals and sites. Mean expected 
coverage is given by: 
 ̂  
                         
                            
  
  
   
 
Equation 4-1 
We introduce notation for a pool design as an     binary matrix,   
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We further define notation for column and row sums of the design matrix: For each pool   we 
denote the number      ∑       of individuals in that pool; for each individual   we denote the 
number       ∑       of pools with that individual. Whenever      and      are constant, as 
will be evident from context, we shall omit the parameters   and  , respectively.  
This setup facilitates a discussion of expected coverage of sites across several parameters. The 
actual coverage, or number of reads that observe a particular nucleotide   on a single haplotype 
of individual   in a pool  , is a random variable     
  with mean  ̂    across all sites    L. The 
distribution of this random variable around its mean may be technology specific. We 
demonstrated elsewhere (Sarin et al. 2008) that     
  for Illumina's short read alignments mirror 






Figure 4-1 Coverage Distribution.  
Observed distribution of coverage of Illumina's Genome Analyzer-2 with a mean coverage  ̂        over a 4-Mbp 
region of C. elegans. The distribution best fits a heavy-tailed Gamma distribution Γ(α,β) with shape parameters α = 
6.3 and   
  
   
. A Poisson distribution is also shown in the figure to compare fits. These results have also been 








The mean expected coverage of each haplotype of the diploid individual   in a particular pool   
is 
 ̂    
      
       
 
Equation 4-3 
Using this, we normalize the binary entries of   (presence or absence of a site on pool  ) to 
formulate    (expected coverage of a site on pool  ): 
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Equation 4-4 
Summing over a column of   , we get the expected coverage of a site from an individual 
accumulated over all pools as  ̂  ∑  ̂    . Likewise, summing across a row gives the expected 
coverage of a site across all individuals on the pool  ̂  ∑  ̂    . Finally, the expected 
cumulative coverage of a site across the whole populations in the pooled arrangement,  ̂ satisfies 
 ̂  ∑  ̂ 
 








Next, we model the sequence of alleles carried by individuals in   as an     matrix  . Each 
element      can take on the values         to register how many copies of the minor allele are 
present in the diploid genome of   at site  .  is the ground reality: It is not known to us a priori, 
but rather is what we wish to ascertain. Reconstructing as much of   as possible is the objective 
of this work.  
Lastly, our expected sequencing results are captured by an     matrix   of nonnegative 
integers. The pool design, ground truth, and expected results are linked by the equation 
      
Equation 4-6 
Each entry      is a tally of the expected number of minor alleles at site   across all individuals 
in pool  .  
Design properties 
As a first step toward successfully designing overlapping pools, we focus on engineering  , such 
that it satisfies the following properties of a good design as best as possible.  
Property 1: D retains carrier identity 
This property states that   must have unique column vectors. Since unique columns serve as 
unique pool signatures of each individual in the cohort, matching the occurrence pattern of a 





associated with that column. Therefore, the design matrix   needs to have at least   unique 
columns.  
Pool signatures for all individuals in the cohort may be defined through a function          
mapping individuals to sets of pools. Here,      denotes the power set (set of all subsets) of  , 
while the pool signature of individual   is denoted     . Formally, the pool signature is defined 
as the set:                  .  
Property 2: D achieves an equitable allocation of sequencing throughput  
All else being equal, there is an equal probability of observing a rare variant carried by any 
individual in the cohort. It can therefore be shown that any unequal allocation of throughput 
(coverage) to certain individuals increases the overall probability of missing a variant in the 
population. While there may often be biological motivation to focus on certain sites (for 
example, where variation is known or expected to be functional), current technological 
limitations restrict selective allocation of coverage within the region of interest.  
Additionally, the goal of resequencing includes discovery of rare variants, rather than 
investigating sites that are already known to be polymorphic. We therefore assume no such 
deliberate preferential coverage, and our aim is to cover all    sites in each of   diploid 
individuals as equally as possible using the   pools at our disposal.  
One direct way to achieve equitability would be for the throughput of each pool to be divided 





constant. In other words,           and          . Summing coverage assigned to an 
individual over all of the pools it is sequenced in, we then get     ̂    
 
  ⁄ .  
Property 3:   is error tolerant 
Modeling the empirical errors introduced into pooled resequencing requires review of the 
different experimental stages and their associated sources of error. The first step in targeted 
resequencing experiments is typically pull-down of the target genomic region by standard direct 
PCR with primers for each amplicon, or by tiling oligonucleotide probes and universal 
amplification. For pooled resequencing, we assume that the entire pool is amplified in a single 
reaction. The region of interest is then randomly sheared into short library fragments, which are 
then single-molecule amplified and end-sequenced. Such sequencing protocols provide millions 
of single or paired-end reads, which are computationally mapped against the reference genomic 
sequence. Errors occur during several stages, depending on the sequencing technology. A good 
pool design should account for errors introduced at each stage and use the redundancy of 
information in high-throughput sequencing for robustness against such errors.  
Modeling error 
We now quantify errors that occur in the sequencing process within the framework of our model. 
Equation 4-6 represents an ideal pooling arrangement, where each value      is an expectation of 
the number of rare alleles we should observe. In reality, the observed number of alleles at      is 
a random variable whose mean is the corresponding expectation. The reason for this randomness 





address three primary sources of error: read error, error due to under-sampling, and error during 
amplification (PCR).  
Read error 
Sequence read errors that cause consensus mismatches occur anywhere in the range of one per 
50–2000 bases (Smith et al. 2008). These are more likely to occur at non-variant sites, and 
therefore show up as false-positives, than occur at variant sites, and be observed as false-
negatives. Traditionally, sequence assembly methods (Li et al. 2008) have used base-call quality 
of reads to assess veracity of base calls across multiple reads. However, in the absence of long-
established support of the base-call quality used by current technologies, likelihood may still be 
evaluated by requiring a minimum threshold   of reads that report a variant in order to call it a 
variant. We assume that this read error occurs at the technology dependent rate of         per 
base pair and is uniform across all pools.  
Under-sampling error 
An individual   is said to be under-sampled at base   if   
  is too small to confidently call  . 
Undersampling is intrinsic to all shotgun sequencing, whether pooled or single sample (E S 
Lander and Waterman 1988). However, pooled experiments are generally carried out due to 
cost/throughput constraints with coverage distributions more prone to under-sampling than 
traditional sequencing (Smith et al. 2008). We define a site to be under-sampled if it is read less 
than   times. The distribution of   
  is therefore key for quantifying under-sampling. We propose 





approximation of the distribution of practical coverage (see Figure 4-1). The shape parameters 
for this distribution that we use in our analysis are elaborated in the Appendix.  
  
  ∼        
Equation 4-7 
    
      ∫      
      ̂  ⁄  
      
 
   
   
   
Equation 4-8 
The number of under-sampled sites is therefore: 
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Equation 4-9 
Equation 4-9 applies to pools just as well as to single-sample sequencing: The parameters that 
determine under-sampling remain unchanged. Furthermore, it applies to overlapping pools, with 
the mean coverage across pools  ̂  still determining under-sampling probability, even if the 
individual coverage per pool is smaller than naïve pooling.  
These principles are best demonstrated by an example. Consider a naïve pool design that offers 
 ̂      coverage to each pooled individual and recommends an under-sampling threshold of 





call. The probability of under-sampling a site in this case is relatively small:             . 
However, to accommodate an overlapping pool design within the same resources as a naïve pool 
design, we would have to distribute total available throughput    over the   pools that an 
individual   occurs in. If our design leads us to sequence each individual of our experiment in 
    pools, then our per-pool coverage would be  ̂    
  
 
  . The chance of under-sampling 
at the given threshold in a specific pool is now high:  (      )     , and yet, base calling 
that is aware of the pool design can distribute the   observations required for calling a new 
variant across all   pools to formulate a new threshold    
 
 
, justifying the same probability of 
under-sampling.  
Note that if a variant fails to be observed at all in a particular pool, the signature of its carrier will 
not be observed accurately, although the presence of the variant will be detected.  
Amplification error 
These errors occur when PCR chemistries erroneously introduce variants like base substitutions 
in the replicated DNA (Freeman et al. 1999; Raeymaekers 2000; Huggett et al. 2005). Depending 
on the enzymes and protocols used, these errors range in frequency from traditional 
specifications of          
   errors per base pair to negligible magnitude for high-fidelity 
chemistries (of the order of          
   errors per base pair). In pooled resequencing, PCR is 
most economically pooled as well, and PCR errors may affect multiple reads in that pool. In 
principle, overlapping pools, each involving separate amplification, are more robust to PCR 





a particular individual participates. Empirically, we observe that practical PCR error rates are 
negligible enough to be ignored compared with other sources of errors.  
Logarithmic signatures 
The binary representation of numbers         uses bit-words of size      . One potential 
design is to use an encoding function          , where each signature  ̅ is one of   unique 
bitwords. For example, a small study cohort of 16 individuals would require          pools 
to generate unique signatures as shown by the first four rows of Figure 4-2. The encoding clearly 
maintains carrier identity: A variant noticed only in pools {1, 4} points to individual 11, whereas 
a variant observed on {1, 3, 4} is carried by individual 12, and so on. However, not every 
individual is sequenced on the same number of pools through this scheme (individual 1 is not on 






Figure 4-2 Resequencing with naïve and log pool designs.  
(A) A total of 16 individuals are divided into groups of two and pooled; (B) 16 distinct pool signatures are created 
using just eight pools. In both cases, the pools on which the variant appears and the variant carrier are marked in 
crimson. 
We revised the design to satisfy the equitability property by appending the 1's complement of 
each word to itself, represented by the last four rows of Figure 4-2. The resulting signatures 





four out of eight pools. The ratio of the number of individuals sequenced to the number of pools 
utilized is given by the code efficiency: 
                
 
      
 
Equation 4-10 
 which grows with  . This schema is extendible to  -ary encodings as follows. Each of the   
individuals is uniquely indexed base-   by       numerals in the range          . A base   
numeral is then mapped to its unique binary signature given by its corresponding vector from the 
standard basis of order  . In other words, first numeral 0 to first  -bit basis vector 0…0001, 
numeral 1 to vector 0…010, numeral 2 to vector 0…100, and so on. A total of         pools 
are required to construct the design. For the general case: 
                
 
       
 
Equation 4-11 
 The continuous version of this expression maximizes at    , and for natural     (ternary 
encoding). We call this family of encodings “logarithmic signature designs,” because the design 
uses the order of a logarithmic number of pools in the size of the study cohort.  
Regardless of under-sampling, determining allele frequency is no more difficult than with a 





(Equation 4-5). If   minor alleles are observed cumulatively, then assuming equitable coverage 




More often than not, N may not be a perfect power of any integral value  . In such a case, we 
may not use the entire spectrum of  -ary signatures (e.g., in a study of only 14 out of 16 
individuals in Figure 4-2). The result is that some pools may sequence fewer individuals than 
others (i.e.,      is not constant), violating the equitable coverage dictum. However, by the 
nature of the design, this variation of      across pools is restricted to 1. In such a case, allele 
frequency calculations are normalized as   
∑   
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 , where ∑      . 
Error-correcting signatures 
While economical, logarithmic signatures fail to satisfy Property 3. They are prone to ambiguous 
carrier identity in the presence of false-negative variant calls. For example, in the design 
illustrated in Figure 4-2, individual 1 is sequenced in pools {5, 6, 7, 8}. Suppose the variant call 
is a false-negative in pool 8 due to under-sampling, but is observed on all others. The resulting 
“incomplete” signature {5, 6, 7} is not sufficient to unambiguously identify the carrier as 
individual 1. In fact, it is equally likely that individual 2 under-sampled in pool 4 elicited such an 
observation. In the general case, a false-negative call in a  -ary signature ambiguates precisely   
individuals as potential carriers.  
We now develop error-correcting designs that are able to unambiguously identify the variant 
carrier, even in the presence of false-negatives. Borrowing from results in coding theory 





identity in the face of false-positives. Consider an individual   with a pool signature  ̅ . 
Intuitively, under-sampling error can be identified and corrected if the incomplete signatures 
resulting from the loss of “1” bits in  ̅  all continue to point to the same individual  . Rather than 
associating an individual with a single signature, such a design reserves an entire set of 
signatures within an “error-space” of  ̅  to individual  . This error space is the set of all the 
signatures   ̅   generatable by converting up to some        number of “1”s to “0”s in   ̅ . The 
larger the  , the more signatures reserved per individual, and consequently, the fewer individuals 
we can multiplex into the pool design. This is the trade-off between efficiency and error 
correction. With a fixed number of pools at its disposal, an error-correcting design has to 
maximize the number individuals it can identify while maintaining a disjoint error space.  
An estimate of the expected coverage of each site     
  also allows us to calculate the expected 
number of pools on which a site   of   may be under-sampled:           
     . We may 
then choose an error-correcting scheme that can handle up to some   false-negatives by setting 
the parameter    . By definition then, a variant observed in as few as       out of some   
pools is sufficient to identify the carrier individual.  
A fixed-length block code assigns each individual in a set some             to code words 
such that each code word is of the same length (but not necessarily the same Hamming weight). 
Logarithmic signatures are a type of fixed-length block code without error-correction ability. 
There is an extensive theory regarding such codes that do offer error correction. Extended binary 
Golay codes (EBGC) are such a type of error-correcting block code. Formally, the EBGC 
consists of a 12-dimensional subspace of the space     





such that any two elements in   differ in at least eight co-ordinates. The code words of   have 
Hamming weight 0, 8, 12, 16, or 24. To satisfy Property 2, we only use those code words of 
Hamming weight 8 (i.e., every pool signature assigns its individual to exactly eight pools). These 
code words of weight 8 are elements of the S(5, 8, 24) Steiner system. The error space of these 
Hamming weight 8 code words is a hyper-sphere of radius    . In other words, all signatures 
generated by up to three false-negatives of  ̅  are reserved for the individual  .  
EBGC has 759 code words of Hamming weight 8. We therefore repeat this coding separately for 
[N/759] subsets of the individuals. We note that similar to logarithmic signatures, equitable 
coverage (Property 2) holds for specific values of  , which in this case its values are divisible by 
759. For other values, coverage is only approximately equitable, as different pools may 






4C. Results  
We assessed the performance of our designs by simulating pools of short read data. We 
downloaded short read sequences from the 1000 Genomes Pilot 3 project 
(www.1000genomes.org) that were available on the Short Read Archive (SRA) in January, 2009. 
The 1000 Genomes Pilot 3 project states that it is a targeted sequencing of the coding region of 
∼1000 genes, while the SRA annotates it as sequence from 1000 to 2000 gene regions and 
conserved elements (5 KB average length), giving an expected total of 5 Mbp sequence. Illumina 
runs from 12 individuals, sequenced using single-end, 51-bp read-length libraries, were selected. 
We created a 123.4-Mbp region of interest from the Human Genome, as outlined in the 
Supplemental material. The individuals show between 4.2 and 5.3 Mb of mapped sequence with 
≥3× coverage, with the notable exception of one individual. From the coverage profile, we 
verified that the exception was due to poor fidelity/low scoring reads for that run, possibly due to 
experimental error. Merging the coverage of all individuals, we identified 6.41 million unique 
sites of high significant coverage.  
We constructed two simulated pool designs of 12 individuals on eight sequencing lanes by 
mixing reads from multiple individuals as detailed in the Supplemental material. Reads for 
individuals and pools were then independently aligned against the same 123.4-Mbp reference 
using MAQ (Li et al. 2008), and SNPs were called on the alignment. Since available algorithms 
call alleles under the assumption that they are looking at reads from a single individual (allele 
frequency 0, 1, or 2), we built our own SNP-calling algorithm for pooled data (refer 





were detected across the 123.4-Mbp region in the identity design (i.e., combining independent 
calls made on each of 12 data sets), of which 10,668 were detected by log pools and 10,868 by 
ECC Pools. Both designs demonstrate a high-fidelity allele frequency prediction, as evidenced 
by data outlined in the Supplemental material.  
Based on the pool signature of each detected variant, we associated a distribution over possible 
carrier individuals. Out of a total of 8618 singletons and doubletons, log pools detected 6270 of 
these variants, while ECC pools detected 6478 of these variants (refer to the table in Supplement 
on Allele Detection). In truth, we ascertained (using the 12 data sets) that 5332 of the variants 
detected by log pooling had a single carrier (either homozygous causing singleton or 
heterozygous causing doubleton), while 5539 of the variants detected by ECC pools had a single 
carrier individual.  
At each of these sites, our algorithm uses the variants pool signature to output a set of equally 
likely candidate individuals (uniform distribution) to be the variant carriers. Log pools associated 
4798 variants with a candidate carrier distribution, while being unable to assign the rest. 
Likewise, ECC pools assigned 5060 variants with a distribution. In some cases, the call is 
ambiguous (multiple individuals are given a uniform probability of being potential carriers), 
while in other cases, the design identifies a single variant carrier.  
Of these calls, 3130 distributions in log design captured the correct individual as one of the 
prospective carriers, while 2907 distributions in ECC design captured the same. Some variants 





multiple prospective individuals. The degree of correctness of these calls show a strong 
correlation to what coverage the site enjoyed on the carrier individual's data set (and, 
consequently, on the pools in which the individual was sequenced). The results confirm our 
hypothesis that error-correcting designs enjoy a considerable advantage in terms of numbers of 
correct calls. In the absence of a suitable paired-end data set, we were unable to assess the ability 
of our designs to characterize structural variants like indels, copy-number changes, and 
transposons.  
We also assessed the performance of our pool designs on synthetic data. In particular, the 
logarithmic and error-correcting pool designs were compared against a no-pooling strategy (one 
individual per pool), and the barcoding strategy. Naïve pooling does not claim to establish carrier 
identity in the first place, and therefore is irrelevant as a benchmark for these results.  
We ran our simulations to identify rare mutations on 500 human individuals, each harboring a 
targeted region of interest whose size we varied from 300 Kbp to 3 Mbp. We pooled these 
individuals over 24 sequence runs, mirroring eight lanes on three Illumina GA-2 machines. Each 
sequence run was given a throughput of 0.5-Gbp mapped sequence, resulting in a total 
throughput offering of 12 Gbp. This translated to a realistic expected per-haplotype coverage 
range of 40× to 4× per individual for the corresponding pool sizes.  
Recent literature (Levy et al. 2007) suggests that ≈518 K high-confidence variations were found 
in a newly sequenced genome, which were undocumented in dbSNP, giving a genome-wide 





at a 1% allele frequency in the general populace, we approximate the likelihood of a singleton in 
a 500 individual (1000 chromosome) cohort to be one in 65 Kb. We randomly inserted mutations 
at this rate to the data set, and further subjected it to PCR and read error. From the resulting 
noisy observations     , we predicted a reality matrix         , which we then compared against 
the ground truth.  
The no-pooling scheme was used to sequence 24 individuals chosen at random from the 500 
individual cohorts. The EBGC scheme uses 24 pools to generate up to 759 code words as 
discussed earlier. We used the first 500 of these in lexicographic order. We used a value of θ = 8 
for logarithmic designs; consequently, also giving us a total of            pools. Barcoding 
also used 24 pools, albeit, effectively simulating 500 distinct pools from their cumulative 
throughput. Each individual was offered a pool of     = 1 Mbp.  
4D.  Discussion  
In this study we tackle the design of resequencing pools, a very current challenge for large-scale 
analysis of genetic variation. To the best of our knowledge, this is the first attempt to develop a 
framework for the design of such pools. We were able to represent real experimental error (as 
observed on Illumina Genome Analyzer-2 runs) within this framework. We introduced a few 
properties that represent quantitative figures of merit by which any pooling scheme may be 
judged. Finally, we presented two original design schemes: logarithmic design and error-
correcting design. Each scheme demonstrated a unique set of advantages and disadvantages, but 





designs themselves reveals that they are both valid approaches, each suited for a varying set of 
requirements. In fact, logarithmic signatures are appropriate when under-sampling is a negligible 
consideration. If there is a relatively high-per-pool throughput available vis-à-vis the amount of 
DNA to be sequenced, a scenario that marginalizes considerations of false-negatives, logarithmic 
designs offer the most promise to find rare variation. Error-correcting designs are best suited for 
more trying experimental conditions, when large population studies must be done within 
minimal resources. These designs can effectively identify variant carriers in spite of noisy 
signals, but concomitantly run the risk of assigning lesser sequencing throughput to other carrier 
individuals in the cohort.  
Our results indicated that both error-correcting designs and logarithmic designs detect most of 
the variation in the cohort, with fidelity and ability both dropping as a function of coverage. Our 
algorithms currently do not attempt to determine carrier identity of more common variations that 
might have higher incidence (doubletons, tripletons, and polytons), and will be the subject of 
future work.  
In conclusion, our proposed framework motivates both analytical and experimental downstream 
studies. Analytically, this study focused at identification of rare mutation carriers. Information 
content in the pooled sequences may facilitate such recovery, particularly if samples are known 
to be related and carry variants identical by descent at the resequenced locus, as demonstrated for 
genotype pools (Beckman et al. 2006). Our computational contribution is particularly useful for 
characterizing human variation by enabling pooled resequencing studies to be conducted with 





Chapter 5. Advice to graduate  students in computational genetics 
Despite the giant strides made over the last two decades, much of the science to extract 
“meaning” from genetics remains to be done. An important genetic feature outside the scope of 
this thesis has been the impact of non-single-nucleotide variation: particularly structural variants 
like inversions, copy number alterations, deletions and duplications. Unlike SNPs, the 
technology to accurately measure these features remained relatively underdeveloped during the 
tenure of my PhD, making them harder to study (and with a high risk of false positive results 
from noisy data). This is not the case anymore. Genetics aside, in my opinion the most 
interesting heritable features will be both non-environmental and non-genetic. This realm of 
epigenetic features will undoubtedly play a huge role in explaining phenotypic variation – either 
independently, or in conjunction with genetics.  Another important point that is never sufficiently 
repeated is that heritability, by definition, is a measure of a population and not of an individual. 
Consequently, an imperfect understanding of population membership can result in inflated 
estimates of population variance, and hence unattainable heritability components. Methods to 
accurately attribute population membership and estimate phenotype variation will play an 
important role in improving predictive power. If you are going to make your PhD research about 
explaining heritability (i.e. building better predictive models), then my advice to you would be to 
internalize the subject material well (Re: textbooks   review papers) before plunging head-first 
into method development with an imperfect understanding of the domain – a mistake that I made 
and would not care to revisit. Lastly, methods to resolve naïve phenotype classifications due to 
unavoidable gaps in our understanding of biology also hold great potential. Besides these 





characterize genome-wide trends, as opposed to methods looking for anecdotal results, and (b) 
new datasets that use the latest technologies can often provide the first insight into an untested 
feature (i.e. low hanging fruit) – but be wary of the price paid in terms of the inaccuracy and 
unreliability of cutting-edge assays. The race to sequence the genome was the zeitgeist of my 
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Chapter 7. Appendix 
Please note that notation is carried over from the appropriate sections of the main text. 
 
 
7A. Statistical Test for Interaction 
Under the null assumption that distal SNPs segregate independently in the population (and are 
therefore in linkage equilibrium), the expected  ⃗⃗-frequency for a pair of distal variables in cases 
can be estimated by  [  ⃗⃗  ⃗⃗ ]       : where    and     are the empirical 1-frequencies of   and 
   respectively. Positive LD in cases results in an increase in the frequency of  ⃗⃗-carriers    ⃗⃗  , 
where LD is measured as a difference between the observed and expected frequency    ⃗⃗
     
  ⃗⃗        . If we denote    ⃗⃗
        ⃗⃗
     as the number of excess  ⃗⃗-carriers in cases, then we 
derive the statistic 
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A similar analysis for controls gives us 
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Consequently, the LD in cases and controls can be contrasted to derive an LD-contrast statistic 
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Equation 7-3 
Under our null-hypothesis, we would expect to see no difference in LD between cases and 
controls, 
       ⃗⃗
       
 
Significant variable-pairs  ⃗ are those for which    ⃗⃗
       , where the     
        
represents the number of standard deviations of the standard normal distribution        
required to achieve a significance level of  . In the interest of clarity, we use the Bonferroni 
significance level without loss of generality (any other multiple test correction approach can be 
plugged in as easily). For example, in a dataset of           SNPs, if we perform 
((       
 
)   ) pairwise tests (4  models tested per SNP-pair as per our binary encoding) 
genome-wide, giving us a significance threshold of            . The LD-contrast cutoff 






7B. Stage-1 filtering step 
Consider a common disease with prevalence   in the population. The LD between any two 
variables  ⃗         in the entire population can be considered a mixture of two distributions  
  ⃗⃗
         ⃗⃗
                 ⃗⃗
        
Equation 7-4 
Assuming that physically unlinked alleles are in population-wide linkage equilibrium – i.e. 
  ⃗⃗
      - we estimate that  [  ⃗⃗
          ⃗⃗
      ]  
  
     
 [  ⃗⃗
       ⃗⃗
      ]. If variable-
pairs exceed a disequilibrium cutoff    ⃗⃗
       
  in cases (i.e. if   ⃗⃗
       
   ⃗⃗
    ), then for the 
variables to remain in population-wide equilibrium, the expected reverse disequilibrium in 
control required to counter the imbalance created by these cases is   [  ⃗⃗
           ⃗⃗
    
    ⃗⃗
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    ]  
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     . Substituting in Equation 2-1 (main text), we get  
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Equation 7-5 
For significant pairs (   ⃗⃗
       ), by assuming the marginal frequencies of both variables are 
approximately equal in cases and controls                        , we get  
  
          √
   
 
    
Equation 7-6 
This result expresses the disequilibrium cutoff   
  in cases as a function of the disequilibrium-





contrast Bonferroni cutoff for a common disease with population prevalence    in a dataset 
with an equal number of cases and controls, from Equation 2-3 we can estimate that in cases 
  
         .  
We say a stage 1 case-only analysis is approximately complete under this prescription, because 
while we have determined the expected value of the statistic for significant pairs, we have not 
characterized the full distribution.  
This approximation depends on standard assumptions, particularly that most alleles have similar 
frequencies in cases and controls. For interactions between variables with large causal or 
protective marginal signals, we make the following observations: (i) For variables whose minor 
allele is enriched in cases (i.e. causal association) the approximation is actually violated in our 
favor:  it underestimates our power to find interactions. (ii) For the converse case, where the 
minor allele is depleted in cases (i.e. protective association), the approximation does indeed 
falter. However, using an ultra-conservative approach in which we lower the stage 1 cutoff for 
candidates to be the same as the stage 2 cutoff (i.e.   
    ), is observed to be sufficient to 
accommodate such violations in practice. In other words, we can largely capture interactions 
between SNPs whose frequency is greater in cases as well as greater in controls (SNPs with main 
effects). Lastly and importantly, these loci have typically already been identified by single-locus 
association and are therefore accessible to a candidate gene based analysis.  
7C. The approximate nature of a stage-1 case-only analysis 
The area enclosed within the orange lines represents the region occupied by significant variable-
pairs in linkage disequilibrium space (LD in cases on the X-axis, controls LD on the Y-axis). The 
three sides of the triangle are the maximum (i.e. positive) LD in cases, the minimum (i.e. 
negative) LD in controls and the LD-contrast threshold used to demarcate significant pairs. The 
dotted vertical line represents the stage 1 cutoff used for shortlisting tuples through a case only 
analysis. The number of significant pairs in the area labeled “Missed” and “Captured” depends 





statistically significant pairs lie in the captured region (see section on Approximately Complete 
Search). 
 
7D. Applying group sampling to a genome-wide scan. 
In the toy example described in the main text, we restricted our discussion to finding pairs of 
variables that occupy a narrow frequency window  . To generalize the approach to a genome-
wide search for significant LD-contrasts, we first partition the entire spectrum of frequencies 
      into   windows               of ranges                respectively, where 





the    variables genome-wide to their appropriate frequency windows (see 7H. ). As before, the 
number of variables in a window    is denoted      , and every variable is assigned to exactly 
one window: ∑            . In practice, we find that using around 50 windows is adequate to 
cover the frequency spectrum even in large datasets of         SNPs. 
Consider any pair of windows        . There are (
 
 
)    such window pairs (including the 
possibility that A=B). For all  ⃗          comprising of one variable          and the other 
         , the minimum and maximum expected  ⃗⃗-frequencies can be derived as per 
Equation 2-5 (main text). If    
  holds for  ⃗, then    ⃗⃗ 
             
  . If    
 is rejected by  ⃗ 
then    ⃗⃗ 
              
  , where      is derived as  
     √
                
 
    
Equation 7-7 
We are required to find the group-sampling parameter values             for this window pair, 
at which we can guarantee that all significant-pairs which reject    
 are observed in at least one 
group with probability greater than the user-specified threshold      . Furthermore, our 
solution             has to be “optimal” in two ways : (i) the false positive rate should be low 
(which requires number of individuals per draw -      - to be large) because these candidates 
will have to be kept in memory, only to be screened out later by stage 2, and (ii) the solution 
should not consume too many compute cycles (large       requires a large number of random 
draws      to achieve the desired power, which in turn drives up the number of compute cycles). 
Details of the optimization procedure we employed to find the best      and      are provided 
below.  
To summarize, group-sampling lets us restrict our test to an exponentially (in     ) small 
fraction                     
      of the pairs of variables in             at minimum 





guarantees that all significant variable pairs will be captured in this fraction of the universe with 
power       . This makes stage 1 of our search experiment extremely rapid.  
Although the sheer size of the universe of combinations                 | can suggest a 
large number of false-positives      in stage 1 overall. We make three observations to alleviate 
this concern: (i) This constitutes an upper bound which (by definition) is rarely encountered in 
empirical data, (ii) Most false-positive pairs are observed in more than one sampled group. 
However, these are stored in memory using a hash-table the very first time they are encountered, 
and have to be tested only once by the stage 2 analysis. The upper bound appears large because it 
does not account for such “over counting”, and finally (iii) A poor stage 1 false-positive rate 
comes at a computational cost, but does not affect the accuracy of the algorithm. False-positive 
candidates like these are screened out in stage 2. 
Details of the optimization procedure: 
Translating Equation 2-5 to our current setting, and expressing   as a function of   gives, 
        
       
 
 ⁄  
               
 
Equation 7-8 
There are a total of (               
 
) potential variable-pairs between these windows. The number 
of pairs that emerge purely by chance over     random draws is estimated as 
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And since    ⃗⃗ 
                





             (
               
 
)                 
      
Equation 7-9 
This gives us an upper bound on the number of pairs that turn up purely by chance. We 
confirmed this bound in practice: since most co-occurring variables are encountered in several 
random draws, they need not be investigated more than once if we record them in a hash-table in 
memory.  We can now find the optimal parameter values      and      that satisfy Equation 7-9 
while minimizing the overall cost function, 
                                                 
Equation 7-10 
where   ,    and    are the cost of shortlisting and validating a chance pair, the cost of a random 
draw, and a Lagrange multiplier to avoid degenerate values of   respectively, while      is the 
indicator function. These costs depend on the particular software implementation and data-
structures used.  
7E. QQ plots for LD-contrast test (sub genome-wide) 
We drew 15 million random pairs of binary variables  ⃗         from the cleaned WTCCC 
dataset, and contrasted their LD between bipolar cases and joint controls. We consider this a 
representative sample of the full space of 400 billion pairs which is computationally difficult to 
test. We observed over-dispersion that suggested a deviation from the null-hypothesis. We 
filtered out pairs with an extremely low expected number of minor allele co-carriers (i.e. remove 
pairs with                      in cases or controls respectively) because these might 
inflate the statistic due to unstable variance estimates. Further, we filtered out pairs comprising 
of SNPs in genetic linkage (<5cM apart) which cannot be treated as independent random 





dispersion of LD-contrast p-values on random pairs of such physically linked SNPs. However, 
since interactions between nearby markers (e.g. neighboring genes or markers within a gene) 
quite possibly comprise a significant portion of the interaction space, modifications to the test 
that can adjust for this variance inflation due to multi-collinearity are the subject of future work. 
Lastly, in addition to WTCCC prescription, we removed SNPs whose CHIAMO genotype-
calling confidence was <95% in >1% of the individuals of the dataset. Conservative filters help 
us avoid false positives when we report pairs in the genome-wide significance range    
            . The resulting QQ plots show that for pairs that pass our filters, the LD-contrast test 
operates on a  robust null-hypothesis and does not suffer from any residual over dispersion in BD 
data          .  
We note here that each QQ plot only presents a subset of randomly chosen variable-pairs out of 
the potential           pairs that exist genome-wide in this dataset. It is computationally 
prohibitive to test (on the order of) a trillion pairs of variables, sort their p-values and plot as 
many points without specialized software and computational infrastructure (indeed, avoiding this 
is the primary motivation of our work) but genomic over-dispersion (inflation of the median 
value) can be estimated robustly with a representative sample of the universe of pairs. 
Additionally, for SNP-pairs that do pass the Bonferroni cut-off genome-wide, we also perform a 







7F. Synthetic dataset construction. 
We tested the accuracy of the randomization algorithm under various simulated scenarios. In 
particular, we were interested  in whether SIXPAC always finds SNP-pairs with a significant 
LD-contrast level at (or above) the computational power requested by user. 
Using the original WTCCC BD case-control cohort, we simulated 3 datasets to contain SNP-
pairs with significant LD-contrast. These datasets capture a range of different scenarios 
concerning disease prevalence levels in the population (1% to 25%), minor allele frequencies of 
interacting SNPs (5% to 40%), as well as mode of interaction (recessiveness and dominance). 
The datasets were synthesized through a technique called chromosomal shuffling, as follows: 
i. First choose one SNP on each chromosome (All MAF 40% for dataset 1, MAF 30% and 






ii. Ascertain that these SNPs presented no discernible marginal significance (p >0.1) according 
to five standard single-locus association tests (allelic, genotypic, trend, dominance and 
recessive) offered by Plink (Purcell et al. 2007).  
 
iii. Next, we introduce LD-contrasts into the dataset without changing the marginal frequencies 
of the SNPs either in cases on controls. To do this, we swap entire chromosomes among 
cases (controls) so as to increase (decrease) the number of co-carriers of minor alleles in 
these cohorts. The ratio of cases/controls to shuffle during each iteration is determined by the 
prevalence estimate. 
For example, we create one additional recessive-recessive co-carrier in the case dataset 
(without affecting the marginal signal) we follow these steps.  
Let  case 2 be recessive at SNP A (chr21) and case 3 be recessive at SNP B (chr22), then: 
(i) swap chromosome 21 of case 1 and case 2  
(ii) swap chromosome 22  of case 1 and case 3.  
Case 1 is now a carrier of the recessive-recessive pair at SNPs A and B. The controls can 
have the number of co-carriers depleted by analogous shuffling.  
 
iv. By shuffling case and control chromosomes in this manner, we simulated 11 interactions 
(between SNPs  on 22 autosomes) in each of the 3 datasets – each interaction at different 
levels of LD-contrast significance from                     (decrements of       . 
Note that because of the discrete nature of the shuffle, it is not always possible to achieve 
accurate LD-contrast p-values in the synthetic data (e.g. 
                                . Instead, after each swap we perform an LD-
contrast test between this SNP-pair to check if the co-carrier imbalance introduced between 
cases and controls is sufficient to provide the required level of significance. We stop when 
we cross this level. 
 
Chromosomal shuffling allows us to effectively manipulate LD between SNPs in cases (and 
controls) without changing the marginal association signal at all. This can be verified by 







And the corresponding Manhattan plot after simulating recessive-recessive co-carriers in the 
cases are exactly identical. 
 
Although differentiating LD in the case and control datasets is not intended to directly confer 
statistical epistasis, we can also analyze these simulated SNP-pairs using the traditional model 
for interaction in a case-control study. This involves applying logistic regression, which tests 
whether the two loci - when considered in conjunction - result in a deviation from multiplicative 
odds. 
First we test whether the SNPs in the synthetic datasets have any main effects  – by testing the 
term    or    term in a logistic regression    
 
   
            , where   and    are binary 
predictor variables that encode : 
i. recessive carrier status for interacting SNPs in dataset1 
i. recessive and dominant carrier status respectively for interacting SNPs in dataset2, or  
ii. dominance carrier status for interacting SNPs in dataset3.   
As the tables below confirm, in all 3 scenarios, LD-contrast does not inflate main-effect 





the     term in a logistic regression using the full model:    (
 
   
)                    . 
We note that increasing LD-contrast is strongly indicative of increasing statistical epistasis on 
this scale (see 3 dataset tables below), although the correlation between the 2 tests is not perfect 
(see discussion elsewhere (Shaun Purcell; Kam-Thong et al. 2010)). Fully elucidating the wide 
range of models and alternate parameterizations that may be visible through such LD-contrasts is 
the subject of future work. 
Table 7-1 Dataset 1: Common × Common Interaction. LD-contrast simulated between a 40% MAF SNP (in 
recessive mode) with a 40% MAF SNP (in recessive mode), disease prevalence 25%. 
Simulated interactions  
(approximate 
significance) 







      
odds ratio 
      
odds ratio 
       
    term 
(epistasis) 
LD-contrast  
chr 1 – chr 2        1.0 1.01 1.6 0.01 8.2E-03 
chr 3 – chr 4        0.99 1.0 2.0 2.0E-04 6.8E-05 
chr 5 – chr 6        1.0 1.0 2.6 3.7E-06 6.0E-07 
chr 7 – chr 8        1.0 1.0 2.9 1.5E-07 8.2E-09 
chr 9 – chr 10         1.0 1.0 3.5 1.7E-09 4.2E-11 
chr 11 – chr 12         1.0 0.99 4.0 1.2E-11 8.9E-13 
chr 13 – chr 14         1.0 0.99 4.2 2.6E-12 7.2E-15 
chr 15 – chr 16         0.99 1.0 4.5 3.6E-14 5.5E-17 
chr 17 – chr 18         1.0 1.0 5.3 3.2E-16 8.2E-19 
chr 19 – chr 20         1.0 0.99 6.3 <2E-16 5.7E-21 
chr 21 – chr 22         1.0 1.0 6.5 <2E-16 3.3E-23 
 
Table 7-2 Dataset 2: Rare × Common Interaction. LD-contrast simulated between a 10% MAF SNP (in dominant 












      
odds ratio 
      
odds ratio   
       
    term 
(epistasis) 
LD-contrast  
chr 1 – chr 2        1.01 0.99 1.7 0.01 8.8E-03 
chr 3 – chr 4        1.01 1.0 2.3 4.0E-04 7.9E-05 
chr 5 – chr 6        0.99 0.99 2.8 4.7E-06 5.9E-07 
chr 7 – chr 8        1.01 1.0 3.4 2.4E-07 6.9E-09 
chr 9 – chr 10         1.0 0.99 3.8 2.7E-09 3.5E-11 
chr 11 – chr 12         1.0 1.0 4.2 2.6E-10 6.9E-13 
chr 13 – chr 14         1.01 0.99 5.4 1.6E-12 6.7E-15 
chr 15 – chr 16         0.99 0.99 5.7 5.7E-14 5.8E-17 
chr 17 – chr 18         1.0 1.0 5.6 1.3E-14 5.3E-19 
chr 19 – chr 20         1.0 1.0 6.0 7.6E-16 9.9E-21 





Table 7-3 Dataset 3: Rare × Rare Interaction. LD-contrast simulated between a 5% MAF SNP (in dominant mode) 
with a  5% MAF SNP (in dominant mode), disease prevalence 1%. 
 
7G. Power of Algorithm  
To confirm that theoretical estimates of algorithm power were matched or exceeded by our 
implementation, we tested SIXPAC on the three simulated datasets, each containing 11 pairwise 
SNP-SNP interactions (LD-contrast) at different levels of significance as described in 
Supplementary Section 3.  
SIXPAC accepts two critical inputs from the user, based on which it calculates search parameters  
1. Significance cutoff as a p-value – all LD-contrasts above this cutoff must be reported. 
2. Power (probability) to find these significant pairs, demanded by the user.  
For the purposes of this simulation experiment, we arbitrarily defined the LD-contrast 
significance cutoff at 3 different realistic values of                                   
       for datasets 1, 2 and 3 respectively. We note that any arbitrary cutoff value, lower or 











      
odds ratio 
      
odds ratio   
       
    term 
(epistasis) 
LD-contrast  
chr 1 – chr 2        1.0 1.0 1.9 0.017 9.4E-03 
chr 3 – chr 4        1.01 1.04 2.8 4.4E-04 5.2E-05 
chr 5 – chr 6        1.0 0.99 3.1 1.8E-05 6.4E-07 
chr 7 – chr 8        1.0 1.0 3.7 7.9E-07 4.2E-09 
chr 9 – chr 10         0.99 0.99 4.0 9.7E-08 8.5E-11 
chr 11 – chr 12         1.0 1.01 5.3 4.6E-10 2.9E-13 
chr 13 – chr 14         0.99 1.01 5.1 8.2E-11 7.5E-15 
chr 15 – chr 16         1.0 1.0 6.2 3.0E-12 8.1E-17 
chr 17 – chr 18         1.0 1.0 6.3 1.7E-13 1.9E-19 
chr 19 – chr 20         1.0 1.0 6.5 7.9E-14 3.4E-21 





we measured results over 5 different realistic values – 45%, 70%, 83%, 91% and 95% 
probability respectively. Here, power of the algorithm is defined as the probability of finding all 
SNP-pairs in the dataset with a significant LD-contrast. As we discussed in the main text, this is 
different from statistical power.  
Each panel in the figure below represents the result of a SIXPAC run with a particular 
combination of power and significance cut-off. The shaded rectangle in each panel represents the 
significance cut-off : interactions below this threshold are not reported.  The solid line represents 
the theoretical power required by the user – and guaranteed as per theoretical estimates. We wish 
to determine whether the interactions to the right of the shaded area are above the cutoff 
threshold line, as promised. 
In the panels below, each interaction is represented by a green dot: the X-axis co-ordinate gives 
the –log(p) value of its LD-contrast, while its Y-axis co-ordinate gives the average observed 
probability of spotting the interaction by SIXPAC (100 runs) - under each particular power, cut-
off setting. We can see that as per guarantees, pairs with an LD-contrast above the significant 
cut-off are always reported with probability greater than the user-prescribed baseline.  
For each dataset, SIXPAC scanned approximately 400 billion pairwise tests (4 tests per SNP-
pair). We report the times taken by each SIXPAC run on a Single Intel i7 processor (quad-core) 
with 8GB RAM alongside. We note that like any randomization algorithm, SIXPAC will require 
an infinite amount of compute time to reach 100% certainty of finding everything in a dataset, 
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7H. Frequency Binning  
 
For each SNP, we consider the empirical frequency of the 2 encoded binary variables in cases 





bin, as shown. Our algorithm operates by considering pairs of windows: since LD is a function of 
the frequency of two variables, we can conversely estimate how frequent a combination would 
need to be in order for the LD to be statistically significant. Group sampling exploits this 
difference in frequency between pairs with significant LD and  pairs in equilibrium to rapidly 
shortlist interaction candidates.  
The optimal width of a frequency window is difficult to characterize analytically : it depends on 
the significance cut-off, statistical test being implemented, number of SNPs typed in the dataset 
as well as the number of samples.  
A. On the one hand, having many windows with a narrow frequency range makes it easy to 
distinguish between statistically significant LD - ( ̃       ) - and a SNP-pair that is at the 
upper end of the frequency spectrum - ( ̃   )
 
. On the positive side, this reduces the 
number of shortlisted candidates per window-pair. However, many narrow windows means a 
quadratic increase in the number of window-pairs that have to be considered – and each pair 
must go through millions of group-sampling iterations, which can be computationally 
expensive. 
B. On the other hand, having fewer but wider frequency windows does not allow group 
sampling to distinguish between a pair with a statistically significant increase in frequency, 
and a pair that is at the upper end of the permitted frequency spectrum - ( ̃       ) and 
( ̃   )
 
 respectively, from the main text. This can result in a large false positive rate at the 
stage 1 shortlisting step.  
For WTCCC size case-control datasets, using the LD-contrast test, at a significance level of 







7I. Numerical Example. 
We describe a particular example of a joint-effect we pursue, in order to provide sense of the 





samples from a population. If the disease prevalence in this population is 4%, then cases are 
oversampled 5-fold by the ascertainment of this study.  
Consider two unlinked SNPs of 5% MAF each (in HWE, same MAF in both cases and controls 
and thus no marginal signal at either). The dominant-variable of each SNP (which encodes 
whether an individual carries    minor alleles at the SNP) has a frequency of 9.75% in both 
datasets, and hence under the null hypothesis we expect 975 and 3,900 dominant carriers among 
the cases and controls respectively. Consequently, around ~95 cases and ~380 controls are 
expected to be “co-carriers” of these alleles when they are in perfect linkage equilibrium in both 
datasets     ⃗⃗
            ⃗⃗
        .  
Now let us assume the specific alternative hypothesis under a certain interaction model (note: 
this may not be the only interaction that an LD-contrast captures, but is used here simply for 
illustrative purposes). Suppose that the disease penetrance for individuals carrying 1 or more 
minor alleles at both SNPs is 5%. If so, we expect to observe just  ~19 fewer controls as co-
carriers, leaving ~361 control co-carriers     ⃗⃗
               . However, this small deflation in 
control co-carriers will be counterbalanced by an overabundance of ~95 co-carriers among cases 
due to the ascertainment bias (5-fold oversampling of cases), resulting in ~190 observed case co-
carriers. This addition of 95 carriers to the background marginal count of 975 dominant carriers 
for each SNP, results in an observed marginal frequency of 10.7% in cases (up from 9.75%). 
Given these marginal frequencies, we would expect ~114.5 dominant co-carriers, which our 
observations exceed by ~75.5     ⃗⃗





Note that a signal of -19 (out of 40,000) vs. +75.5 (out of 10,000) co-carriers is highly significant 
   ⃗⃗
                     ⃗⃗
                 ⃗⃗
                      , and will pass 
the multiple testing burden of all pairs of variables in most experiments. In particular, we note 
here that the LD-case statistic was even more extreme and indicative of a significant LD-
contrast, just as we had concluded in the section on Approximately Complete Search. 
Group sampling utilizes this difference in co-carrier frequencies as follows. If the dominant × 
dominant allelic combination was in perfect linkage equilibrium in both datasets, then by 
randomly sampling       cases, the probability of all 4 cases being co-carriers by chance is 
                . In the alternative situation when there is penetrance of co-carriers, this 
probability is                 . If we draw     such groups of cases at random, then the 
probability that we will sample all co-carriers at least once is >12% if they are synergistic, while 
it is <0.7% if they are not. In this manner, group sampling makes it highly plausible that the 
joint-effects pair of variants will be observed under the alternative, not so under the null. 
Because group sampling utilizes Binary computer operations, even a million random draws can 
be accomplished in relatively insignificant amount of  time. 
7J. Application of SIXPAC in functional enrichment designs. 
SIXPAC requires its user to provide two search parameters which are pertinent to this 
experiment: (i) a significance threshold, and (ii) a power setting. The significance threshold, 
which is provided as a p-value, tells SIXPAC to only report SNP-pairs whose epistasis term 





cutoff) results in an increase in computational costs that can quickly make our study design 
intractable. In addition to the computational savings, there is also a statistical rationale to this: 
high p-values represent diminished evidence of epistasis, thereby increasing the proportion of 
false-positives (truly non-epistatic combinations) in our list. In other words, the proportion of 
statistical signal gleaned to statistical noise added (our metaphorical bang-for-buck) by lowering 
the threshold keeps decreasing. As a practical balance, we use a threshold of           
  , 
which is roughly a million-fold more relaxed that the Bonferroni significance levels (       . 
The pvalues of SNP-pairs that are not reported by this search are set to 1.  
The power parameter of SIXPAC denotes the probability with which the list of SNP-pairs 
reported at the end of the search is complete. One of the key properties of SIXPAC is its use of 
randomization to achieve computational speedup at the cost of certainty. Once again, increasing 
certainty comes at the cost of disproportionate compute time. We apply SIXPAC to 95% 
certainty – in other words, there remains a 5% chance that the list is incomplete (alternately, we 
expect to miss 5% of SNP-pairs whose epistasis stands at       ). However, since we apply 
the same search parameters on every permuted dataset as well, we are reasonably protected 






7K. LOD contrast statistic vs. Logistic regression 
The usual scale applied to test for statistical epistasis between a pair of variants          and 
         – where 0 and 1 represent reference and mutant allele respectively – is to check 
whether the combined effect size of carrying mutant alleles at both loci (measured as the log of 
odds ratio) deviates from the addition of their individual effect sizes. This is typically 
accomplished by comparing the fit of two separate logistic regression models on the dataset of 
cases                   and controls                  .  
Under the null model   of additive effect (i.e. no epistasis) 
   (
      
      
)               
provides a sufficient fit, whereas under the alternate model     of deviation from additive log 
odds (i.e. epistasis) 
   (
      
      
)                       
provides a significantly better fit. When the residual deviance captured by the interaction term 






        
      
          
             
             
 
The disadvantage of this approach is that each logistic regression requires a computationally 
expensive numerical iteration procedure to converge to the MLE of its coefficients. Instead of 
performing a logistic regression, SIXPAC applies an analytical derived closed form that is faster 
to compute, and yet provides an equivalent result.  
The LOD-contrast statistic (described here (Wu et al. 2010), and corrected here (Ueki and 
Cordell 2012)) is easy to compute and mirrors the logistic regression based likelihood-ratio 
statistic for statistical epistasis. Therefore, by applying the LOD-contrast statistic SIXPAC 
manages the same search in a few hours on a single computer – allowing us to perform the 
thousands of genome-wide scans required by our permutation scheme. The LOD contrast 
statistic is given by 
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Equation 7-11 
           
       
          
             





The perfect concordance of this test with logistic regression is seen below in figure, while the 
validity of the null hypothesis ( that the statistic is distributed as      
  ) is seen from the QQ plot 











7L. Functional enrichment statistics 
The statistics we employ have been well studied and characterized in marginal enrichment. In 
particular, both Simes correction and Fisher’s combination test have been proven to be the most 
powerful. We directly extend the insights made by others to our work. We note that though the 
Simes correction is a fairly conservative procedure for positively correlated tests, it tightly 
controls the false positive rate (Li et al. 2011). Other tests like Fisher’s combination test combine 
information from multiple epistatic SNP-pairs which gives an intuitively more appealing 
measure of gene-gene epistasis, but can be too liberal when tests are correlated – as is our case 





confident of the results, but future extensions may need to devise more statistically powerful 
alternatives to find even more pathway interactions. 
7M. Equitable distribution of sequence coverage 
Equitable distribution mandates an equal coverage to all pooled individuals in order to maximize 
the probability of observing a rare variant and identifying its carrier. This may be seen as 
follows: Consider a pooling of two individuals a and b, given unequal overall coverages  ̂  
 ̂ . By Equation 4-9, we get a total number of false negatives for a site as 
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           ∫  
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where αa = αb = 6.3, while βa < βb are shape parameters by Equation 4-8.  
Under equitable allocation  ̂  
  ̂   ̂  
 
, it may be shown that                   
    
  . 
That is, 
 ∫         
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For example, if individual a has an overall coverage 8×, while individual b has overall coverage 
4×, their independent under-sampling rates at threshold 2 are 0.3% and 7.7%, respectively. 
However, at a mean coverage of 6× across both, the probability of a FN is 1.4%.  
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